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ABSTRACT 
 
 
 
Julia M. Hum 
 
 
SIGNALING MECHANISMS THAT SUPPRESS THE ANABOLIC RESPONSE 
OF OSTEOBLASTS AND OSTEOCYTES TO FLUID SHEAR STRESS 
  
 Bone is a dynamic organ that responds to its external environment. Cell 
signaling cascades are initiated within bone cells when changes in mechanical 
loading occur.  To describe these molecular signaling networks that sense a 
mechanical signal and convert it into a transcriptional response, we proposed the 
mechanosome model.  “GO” and “STOP” mechansomes contain an adhesion-
associated protein and a nucleocytoplasmic shuttling transcription factor.  “GO” 
mechanosomes functions to promote the anabolic response of bone to 
mechanical loading, while “STOP” mechanosomes function to suppress the 
anabolic response of bone to mechanical loading.  While much work has been 
done to describe the molecular mechanisms that enhance the anabolic response 
of bone to loading, less is known about the signaling mechanisms that suppress 
bone’s response to loading.  We studied two adhesion-associated proteins, Src 
and Pyk2, which may function as “STOP” mechanosomes.  Src kinase is 
involved in a number of signaling pathways that respond to changes in external 
loads on bone.  An inhibition of Src causes an increase in the expression of the 
anabolic bone gene osteocalcin.  Additionally, mechanical stimulation of 
	  vii 
osteoblasts and osteocytes by fluid shear stress further enhanced expression of 
osteocalcin when Src activity was inhibited.  Importantly, fluid shear stress 
stimulated an increase in nuclear Src activation and activity.  The mechanism by 
which Src participates in attenuating anabolic gene transcription remains 
unknown.  The studies described here suggest Src and Pyk2 increase their 
association in response to fluid shear stress.  Pyk2, a protein-tyrosine kinase, 
exhibits nucleocytoplasmic shuttling, increased association with methyl-CpG-
binding protein 2 (MBD2), and suppression of osteopontin expression in 
response to fluid shear stress.  MBD2, known to be involved in DNA methylation 
and interpretation of DNA methylation patterns, may aid in fluid shear stress-
induced suppression of anabolic bone genes.  We conclude that both Src and 
Pyk2 play a role in regulating bone mass, possibly through a complex with 
MBD2, and function to limit the anabolic response of bone cells to fluid shear 
stress through the suppression of anabolic bone gene expression.  Taken 
together, these data support the hypothesis that “STOP” mechanosomes exist 
and their activity is simulated in response to fluid shear stress. 
 
Fredrick M. Pavalko, Ph.D., Chair 
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Chapter I 
INTRODUCTION 
 
Mechanical Regulation of Bone 
 
Bone Development  
 The skeleton serves to protect, support, and act as a reservoir for 
metabolic activity.  It must be rigid enough to protect the vital organs of the body, 
lightweight to support mobility, yet also capable of adapting to its external 
environment (Ehrlich and Lanyon, 2002).  Bone is a highly specialized form of 
connective tissue and a dynamic organ which develops through two different 
types of formation, intramembranous and endochondral (Miller et al., 2007).  
Intramembranous bone formation is direct bone synthesis mediated by the inner 
periosteal osteogeneic layer.  Endochondral bone formation results in indirect 
synthesis of bone from a cartilage scaffold and is responsible for the 
development of long bones in the longitudinal direction.  Bone development 
begins with a phase called modeling, a metabolic activity involving the deposition 
of mineralized tissue where a cartilage equivalent existed (Raisz, 1999).  During 
modeling, endochondral bone formation systematically replaces cartilage with 
bone. Remodeling follows the modeling phase, while remodeling begins in early 
fetal development, it is the primary metabolic activity occurring in a fully formed 
skeleton.  In general, bone remodeling is a finely tuned cellular process that 
involves the concerted efforts of osteoblasts, which secrete bone matrix, and 
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osteoclasts, which resorbs the bone matrix.  If the balance of bone remodeling is 
slightly shifted it can lead to a metabolic diseases such as osteoporosis or 
osteopetrosis (Boyce et al., 1992).   
 More specifically, remodeling is a highly regulated, multi-step process 
initiated by the interactions of cells from the hematopoietic osteoclastic and 
mesenchymal osteoblastic lineages (Miller et al., 2007).  Remodeling begins 
when these two types of precursor cells interact, causing the formation of large 
multinucleated osteoclasts.  Osteoclasts function to resorb bone by attaching 
directly to the surface of bone and secreting enzymes and hydrogen ions to 
degrade the bone matrix.  Osteoclasts form resorption pits on the surface of 
bone, subsequently increasing the local calcium concentration and signaling the 
reversal stage.  During the reversal stage mononuclear cells release growth 
factors and deposit proteoglycans on the surface of bone.  Bone is formed during 
the final formation stage, in which osteoblasts line the resorption pit and deposit 
a mineralizable matrix.  During the formation phase some osteoblasts become 
entombed in the new bone matrix and mature into osteocytes.  Osteocytes 
account for 90-96% of mature bone tissue and are responsible for the 
maintaining the bone matrix (Schaffler and Kennedy, 2012).  Each osteocyte 
resides in a lacuna within the bone matrix, and extends processes through the 
canaliculi to connect with processes from adjacent osteocytes.  This creates a 
large osteocyte communication network, made up of osteocytic processes within 
the bone matrix.  In summary, while the skeleton may appear to be a rigid 
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structure, the bone tissue comprising our skeletal system undergoes dynamic 
remodeling which can be initiated in different ways.  
 
Regulation of bone formation and remodeling 
 Two of the main mechanisms by which new bone formation occurs, 
include hormonal regulation and mechanical loading (Miller et al., 2007; Sheffield 
et al., 1987).  Both vitamin D and parathyroid hormone (PTH) function to regulate 
calcium and have a major effect on bone remodeling (Blair et al., 2002; Suda et 
al., 2003).  In general, vitamin D serves to reduce bone formation, while PTH 
serves to promote bone formation.  Briefly, vitamin D regulates phosphorous and 
calcium transport and promotes osteoclast differentiation (Bikle, 2012).  Both 
vitamin D and PTH increase osteoclast formation indirectly through increased 
production of the receptor activator of NF-ĸB ligand (RANKL) in osteoblasts.  
Osteoclast differentiation and maturation occur when RANKL binds to RANK 
receptors on the surface of osteoclast precursors (Blair et al., 2002; O'Brien et 
al., 1999; Suda et al., 2003).  When serum calcium levels are low PTH is 
secreted and activates both osteoclast and osteoblast differentiation (Blair et al., 
2002).   
 In contrast to their effects on osteoclasts, vitamin D and PTH oppose each 
other’s effects on osteoblast differentiation.  PTH promotes osteoblast survival in 
vitro and increases osteoblast differentiation by activating the Runx2 transcription 
factor (Jilka et al., 1999; Krishnan et al., 2003; Merciris et al., 2007; 
Selvamurugan et al., 2000).  Runx2 was the first osteoblast specific transcription 
	  4 
	  
factor identified (Ducy et al., 1997; Otto et al., 1997) and is considered the 
“master” regulator for bone formation (Ducy et al., 2000; Franceschi, 1999; 
Komori et al., 1997).  Overall PTH functions to increase bone formation by 
osteoblasts and mineral degradation by osteoclasts (Blair et al., 2002).  
Alternatively, vitamin D functions to inhibit osteoblast differentiation by negatively 
regulating Runx2 and type-I collagen, but is required for bone degradation and 
mineralization (Blair et al., 2002; Ducy et al., 1997; Suda et al., 2003).  Hormonal 
signals target all three kinds of bone cells to cause changes in gene transcription, 
resulting in either enhanced or reduced bone formation via the remodeling 
process.   
 Mechanical loading of the skeleton also induces bone formation, through 
the regulation of the bone remodeling process.  It has long been established that 
bone responds to changes in its external environment and new bone formation 
occurs in response to mechanical loading (Goodship et al., 1979; Lanyon, 1984; 
Lanyon and Rubin, 1984; Wolff, 1892).  Reducing mechanical load, for instance 
during space flight or prolonged bed rest, causes bone loss (Collet et al., 1997; 
Vogel and Whittle, 1976).  Bone responds differently to the magnitude and rate of 
strain.  High strain changing at fast rates induces more bone formation than low 
strain or slow rate of strain (Honda et al., 2001; Mosley and Lanyon, 1998; 
O'Connor et al., 1982; Rubin et al., 1987).  This finding explains why high impact 
exercises result in more bone formation than low impact activities (Nordstrom et 
al., 1998a; Nordstrom et al., 1998b).  Additionally, bones have a greater 
osteogenic response to repetitive bouts of mechanical loading with rest periods 
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than persistent loading cycles (Robling et al., 2000).  The external environment of 
bone has a major impact on its architecture.  The following sections will explain 
the structure of bone, its biomechanical properties, and the major signaling 
cascades that mediate the response to mechanical loading. 
 
Structural and Mechanical Properties of Bone 
 In order for the skeleton to carryout its primary functions it must maintain 
an architecture that is both strong and lightweight.  Bone accomplishes this 
structural feat by being curved, allowing bones to withstand remarkable amounts 
of strain, but remain lightweight (Turner and Burr, 1993).  Throughout its 
development and growth, bone is adapting its shape to the external demands 
placed on the skeleton (Balling et al., 1992).  As previously described, bone 
modeling and remodeling allow for maintenance of its unique architecture, as 
well as adapt to its external environment (Robling et al., 2002).   
 The two main types of bone, cortical and trabecular, play distinctly 
different structural and functional roles.  Cortical bone is made up of a network of 
highly organized, densely packed collagen fibrils forming concentric lamellae 
(Marks and Hermey, 1996).  Within cortical bone Haversian canals form channels 
that contain the bone’s supply of blood vessels and nerves.  Functionally, cortical 
bone provides strength, protection, and mechanical support.  Cortical bone is 
found primarily in the long bones of the skeleton, for instance the arms and legs.  
In contrast, trabecular bone is loosely organized and composed of a porous 
matrix, allowing it to be adaptable and serve its metabolic functions primarily at 
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the ends of bone.  Wolff first observed that trabecular bone was present at the 
sites of maximum stress on bones, while areas of minor stress lacked trabecular 
bone (Wolff, 1892).  Frost elaborated further on Wolff’s observation in his 
description of the mechanostat theory (Frost, 1987).  Frost’s theory states that an 
ideal strain range exists for bone.  When increased strain is experienced by an 
area of bone it responds by depositing new bone matrix in an effort to lower the 
amount of strain.  Likewise, if the strain experienced by bone is below the ideal 
range, bone will be resorbed in an effort to revert back to the preferred range.  
 Over the years research has focused on explaining the molecular 
mechanisms that bone uses to respond to its external environment.  Studies 
have measured the amount of strain on bone in vivo and methods have been 
developed to investigate the effects of mechanical loading on bone (Hert et al., 
1971; O'Connor et al., 1982).  These findings lead to the expansion of the field of 
bone cell mechanotransduction. 
 
Bone Cell Mechanotransduction 
 Mechanotransduction is the conversion of mechanical signals into cellular 
biochemical responses (French, 1992).  Examples of mechanotransduction in the 
human body include, the role of blood flow in vascular tone (Davies, 1995), hair 
cells’ ability to detect and amplify sound (LeMasurier and Gillespie, 2005), and 
bone responding to changes in its external environment through remodeling 
(Turner and Pavalko, 1998).  The external environment of bone produces tension 
and compression forces, causing bones to bend, resulting in fluctuating interstitial 
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fluid pressure throughout the lacuno-canalicular system.  Changes in interstitial 
fluid shear stress are seen across the surface of osteoblasts and osteocytes.  
Mathematical models have estimated the physiologic range of fluid shear stress 
within the lacunae and canalicular spaces to be between 8 – 30 dynes/cm2 
(Weinbaum et al., 1994).  To further investigate mechanotransduction in bone 
cells numerous models have been designed to mimic a mechanical stimulus on 
bone cells, including hydrostatic pressure (Burger et al., 1992; Ozawa et al., 
1990; Shelton and el Haj, 1992), substrate distension (Meikle et al., 1984; Murray 
and Rushton, 1990; Somjen et al., 1980) or bending (Bottlang et al., 1997; 
Pitsillides et al., 1995), and fluid shear stress (Dewey, 1984; Frangos et al., 1985; 
Sakai et al., 1999).  While all of the aforementioned models have significantly 
contributed to our understanding of mechanotransduction, bone cells appear to 
be more responsive to fluid shear stress models than strain models (Owan et al., 
1997; Smalt et al., 1997).  Further discussion of fluid shear stress models will 
occur in a subsequent section. 
 Both osteoblasts and osteocytes are exposed to changes in interstitial 
fluid flow (Hillsley and Frangos, 1994; Turner and Pavalko, 1998).  However, the 
osteocyte is thought to be the primary bone cell responsible for responding to 
mechanical loads.  Known as the “great communicator” osteocytes detect strain 
from within their lacunae entombed in bone matrix (Bonewald, 2011; Cowin, 
1998).  A communication network is set up among osteocytes throughout the 
bone matrix by their processes.  The processes of osteocytes transmit 
mechanical signals through their network via gap junction linkages (Cheng et al., 
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2001a; Cheng et al., 2001b; Jiang and Cheng, 2001).  Osteocytes’ role in 
mechanical loading was highlighted in a seminal study in which osteocytes were 
targeted for ablation leading to defective mechanotransduction in mice (Tatsumi 
et al., 2007).  One key difference between the response of osteocytes and 
osteoblasts to mechanical loading is the secretion of sclerostin.  A protein 
product of the SOST gene, sclerostin is only secreted by osteocytes and is a 
powerful inhibitor of bone formation (Brunkow et al., 2001).  SOST null mice 
exhibit increased bone formation and strength (Li et al., 2008).  In response to 
mechanical loading, osteocytes reduce sclerostin secretion, whereas the 
secretion is increased under reduced loading (Robling et al., 2008).  Thus it 
appears that sclerostin secretion is a central mechanism by which osteocytes 
control local osteogeneis.  Mice, rats, and nonhuman primates treated with a 
sclerostin-neutralizing antibody demonstrated increased anabolic bone formation 
(Li et al., 2009; Li et al., 2010; Ominsky et al., 2011; Ominsky et al., 2010).  
Sclerostin, a suppressor of anabolic bone formation, is proving to be a promising 
target for pharmacological intervention.  This type of osteogenic suppression is 
the focus of this dissertation project.   
 Besides the secretion of sclerostin, osteocytes and osteoblasts otherwise 
respond to mechanical loading by initiating similar signaling cascades.  Many 
complex signaling cascades work in concert to ensure bone responds properly to 
its external environment.  The main signaling cascades utilized by osteoblasts 
and osteocytes to respond to changes in their external environment include 
calcium, prostaglandins, MAPK, Wnt, growth factors, PTH, TNFα, and focal 
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adhesion (FA) integrin-mediated signaling cascades (Liedert et al., 2006; 
Thompson et al., 2012).  In general, most of these pathways lead to in changes 
in bone cell proliferation, differentiation, metabolic activity, and survival. 
 A rapid increase in intracellular calcium (Ca2+) is one of the first cellular 
responses to fluid shear stress (el Haj et al., 1999).  Ca2+ channels on the 
plasma membrane are mechanosenstive and open in response to fluid shear 
stress (Iqbal and Zaidi, 2005).  A change in the plasma membrane’s potential is 
triggered by the increased Ca2+, which causes the voltage-sensitive Ca2+ 
channels to open, further increasing intracellular Ca2+ (el Haj et al., 1999).  
Subsequently, the cell releases adenosine triphosphate (ATP), which acts in an 
autocrine/paracrine fashion, binding to the purigenic P2X receptors to cause 
further extracelluar Ca2+ entry into the cell (Li et al., 2005).  Additionally, 
phospholipase C is activated and cleavage of phosphoinositol-4,5-bisphosphate 
into diacyglycerol and inositol trisphosphate (IP3) results from ATP binding to 
P2Y receptors (Genetos et al., 2005).  Intracellular stores of Ca2+ are then 
released when IP3 then binds to its receptor on the endoplasmic reticulum 
 Prostaglandin release is a rapid and continuous occurrence throughout 
the duration of fluid shear stress exposure (Bakker et al., 2001).  As intracellular 
Ca2+ levels increase, PKC is activated and induces phospholipase A2 to cleave 
arachidonic acid from the plasma membrane (Kudo and Murakami, 2002; 
Murakami and Kudo, 2002).  Arachidonic acid is converted into prostaglandin-G2 
(PGH2) and H2 by the rate limiting enzyme cyclooxygenase 2 (Cox-2) 
(Herschman, 1994).  Next, PGH2 is converted into various eicosanoids including 
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prostaglandin E2 (PGE2) and PGI2 (Dubois et al., 1998).  When prostaglandins 
are secreted from a bone cell they are capable of autocrine and paracrine 
signaling.  The significance of prostaglandins on bone was demonstrated when 
treatment with PGE2 stimulated osteoblast differentiation (Zhang et al., 2002), 
bone formation (Jee et al., 1985; Jorgensen et al., 1988), and increased release 
of the important growth factor, insulin-like growth factor 1 (McCarthy et al., 1991; 
Zaman et al., 1997).  Additionally, the importance of Cox-2 was demonstrated by 
showing that load-induced bone-formation was blocked by an inhibitor, NS-398 
(Forwood, 1996).  In response to fluid shear stress, an increase in Cox-2 
expression is recognized as an indication of the anabolic response of bone cells 
(Pavalko et al., 1998b). 
 Downstream of Ca2+ increase and prostaglandin release, fluid shear stress 
results in the activation MAPK signaling cascade, which functions to increase 
bone cell proliferation and survival (Liedert et al., 2006).  Periods of fluid shear 
stress result in the activation of the extracellular signal-related kinase (ERK), 
p38, mitogen activated protein kinases (MAPKs), and c-jun N-terminal kinase 
(JNK) (Liedert et al., 2006; Martineau and Gardiner, 2001).  All of these signaling 
molecules target the upregulation of c-fos and c-jun expression, the two 
components of the activator protein-1 (AP1) transcription factor.  AP1 can bind to 
the promoter region of many mechanoresponsive genes, affecting their 
transcription in response to mechanical loading (Franceschi, 2003).  Shear stress 
response element (SSRE) is another significant transcription factor-binding site 
activated in response to mechanical loading (Nomura and Takano-Yamamoto, 
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2000).  A SSRE was found in several genes including the aforementioned COX-
2.  In MC3T3 osteoblastic cells exposure to fluid shear stress induces an 
increase in Cox-2 expression, mediated by AP-1, CCAAT/enhancer-binding 
protein β, and cAMP-response element-binding protein (CREB) (Ogasawara et 
al., 2001).  
Mechanical stimulation leads to increased activity of the canonical Wnt 
signaling pathway.  During active signaling, a Wnt family member (Wnt 3, 5, or 7) 
bind co-receptors Frizzled and low-density lipoprotein receptor-related protein 5/6 
(LRP5/6), causing the accumulation of β-catenin (Lin and Hankenson, 2011; 
Monroe et al., 2012).  The central signaling protein of the Wnt signaling pathway, 
β-catenin, translocates to the nucleus and associates with the transcription factor 
LEF1 to activate transcription of target genes.  When Wnt is unbound to its co-
receptors, β-catenin’s accumulation is prevented by glycogen synthase kinase-
3’s phosphorylation, targeting β-catenin for degradation.  Fluid shear stress 
induces β-catenin nuclear translocation in osteoblasts and osteocytes (Case et 
al., 2008; Kamel et al., 2010; Norvell et al., 2004).  In the bone field, intense 
research interest has surrounded the canonical Wnt signaling pathway due to 
recent major advances.  Mutations in the LRP5 receptor result in dramatic 
changes in bone mass.  Activating mutations in LRP5 cause high bone mass 
phenotype (Boyden et al., 2002; Little et al., 2002; Qiu et al., 2007), while 
inactivating mutations cause a low bone mass phenotype (Gong et al., 2001; Qiu 
et al., 2007).  Furthermore, β-catenin is a central signaling component in bone 
differentiation, formation, and maintenance.  A conditional β-catenin knockout in 
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mesenchymal progenitor cells caused disrupted chondrocyte formation and 
limited osteoblast differentiation (Day et al., 2005).  Mice expressing an 
osteoblast-specific β-catenin mutation had an osteopenic phenotype and an 
abundance of osteoclasts (Holmen et al., 2005).  β-catenin’s ability to serve as 
an important component within fluid shear stress-induced mechansomes will be 
discussed in a later section. 
Upregulation of growth factors including insulin-like growth factor (IGF) I 
and II, transforming growth factor (TGF) β1, vascular endothelial growth factor, 
and bone morphogenetic protein (BMP) 2 and 4 occurs in response to 
mechanical stimulation (Franceschi and Xiao, 2003; Papachroni et al., 2009).  
These growth factors act through autocrine and paracrine mechanisms, via their 
tyrosine and serine/threonine kinase receptors, and activate PI3K, MAPK, and 
SMAD signaling cascades (Farhadieh et al., 2004; Hughes-Fulford, 2004; Mikuni-
Takagaki, 1999).  For example, the induction of the BMP-2 pathway increases 
the expression of the three most pivotal osteogenic transcription factors Runx2, 
osterix, and Dlx5 (Lee et al., 2003). 
Additionally, PTH signaling is also stimulated in response to mechanical 
loading.  PTH signals in bone cells through the G protein-coupled receptor 
(GPCR) at the plasma membrane, inducing the activation of adenylate cyclase.  
Consequently protein kinase A phosphorylates the CREB transcription factor, 
which binds to the Cox-2 promoter (Ogasawara et al., 2001).  Many of the 
signaling pathways reviewed here lead to increased bone cell proliferation and 
differentiation.  However, it has been estimated that more than 70% of 
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osteoblasts at sites of bone formation undergo apoptosis (Jilka et al., 1998).  
Therefore, it has been proposed that inhibiting osteoblast apoptosis pathways 
might be an important mechanism by which new bone formation could be 
increased. 
Osteoblasts treated with tumor necrosis factor-alpha (TNFα), an 
apoptosis-inducing agent, and exposed to fluid shear stress experienced less 
apoptosis than the static control osteoblasts treated with TNFα (Pavalko et al., 
2003a).  This study demonstrated that phosphorylation and activation of the pro-
survival protein Akt was increased in response to fluid shear stress.  Next, Akt 
inactivates proteases that initiate the apoptotic pathway.  In addition, Akt 
phosphorylates the inhibitor of kappa B (IκB), promoting its degradation and 
permitting the nuclear translocation of nuclear factor-κB (NF-κB) (Chen and 
Goeddel, 2002).  NF-κB is a transcription factor that controls the expression of 
many pro-survival genes.  Additionally, fluid shear stress causes a reduction in 
the amount of TNFα receptor at the plasma membrane and decreased TNFα-
induced interleukin 8 promoter activity (Wang et al., 2011).  Fluid shear stress 
causes bone cells to be less apoptotic, and seemingly promote a larger 
osteoblast population capable of producing more bone.  In summary, in response 
to fluid shear stress, many signaling cascades are initiated that result in changes 
in gene transcription and ultimately effect the bone remodeling process.  While 
many of the pathways involved in bone cells’ response to fluid shear stress have 
been elucidated, some molecular details from each signaling cascade are 
unknown.  For example, it is not known whether a molecule or protein complex 
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functions to directly convert the mechanical signal into a change in gene 
transcription. The following section will review the mechanosome hypothesis and 
the signaling molecules that may function within them.  
 
 
Signaling Through Focal Adhesions 
 
The Mechanosome Model 
 We have proposed the mechanosome model to describe how mechanical 
stimuli sensed at the plasma membrane, result in changes in gene transcription 
(Bidwell and Pavalko, 2010; Bidwell and Pavalko, 2011; Pavalko et al., 2003b).  
A mechanosome consists of an adhesion-associated protein and a 
nucleocytoplasmic shuttling transcription factor.  There are two forms of 
mechanosomes, a “GO” mechanosome and a “STOP” mechanosome.  A “GO” 
mechanosome functions to promote the anabolic response of bone to 
mechanical loading, while a “STOP” mechanosome functions to suppress the 
anabolic response of bone to loading (Figure 1).  β-cateinin and Lef1 are an 
example of a “GO” mechanosome.  In response to fluid shear stress β-catenin 
moves away from its structural role at the plasma membrane and translocates to 
the nucleus to bind the transcription factor, lef1, to change gene transcription 
(Norvell et al., 2004; Yang et al., 2010).  Nuclear matrix protein 4 (NMP4) and 
130 kD Crk-associated substrate (p130Cas) function as a “STOP” mechanosome 
(Childress et al., 2010).  NMP4 is a nucleocytoplasmic shuttling protein that 
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inhibits bone anabolism through its function as a trans-acting protein and can 
antagonize β-catenin/Lef1 “GO” mechanosome launching (Hino et al., 2007; 
Morinobu et al., 2005; Robling et al., 2009; Thunyakitpisal et al., 2001; Yang et 
al., 2010).  Another component of this “STOP” mechanosome, p130Cas, is an 
adhesion-associated protein known to be mechanosensor (Geiger, 2006; 
Sawada et al., 2006).  Additionally, the Pilz group has recently described a 
mechanosome made up of protein kinase G, Src and Src homology 2 domain-
containing tyrosine phosphatase 1 and 2 (Rangaswami et al., 2010).  The 
subsequent sections will review one of the launching sites of mechanosomes, 
focal adhesions and some key molecules that may function as part of a 
mechanosome. 
 
 
 
 
 
 
 
 
 
 
 
 
	  16 
	  
Figure 1. The Mechanosome Hypothesis 
 
The “GO” and “STOP” mechanosome model in response to OFSS. 
Mechanosomes form in three basic steps in response to OFSS. First, OFSS 
induces the activation of an adhesion-associated protein found sites of adhesion 
near the plasma membrane.  Second, a mechanosome is formed when it 
complexes with a transcription factor.  Finally, the mechanosome either promotes 
(“GO”) or suppresses (“STOP”) gene transcription.  Modified figure from Bidwell 
and Pavalko, 2011. 
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Focal Adhesions 
 One of the two components of a mechanosome is an adhesion-associated 
protein.  In bone cells, numerous adhesion-associated proteins are found on the 
cytoplasmic side of focal adhesions (FA’s).  First described as small extended 
regions of the ventral plasma membrane, FA’s tightly join cells to the substrate 
(Abercrombie and Dunn, 1975; Abercrombie et al., 1971; Izzard and Lochner, 
1976; Izzard and Lochner, 1980).  FA’s have two distinct roles, to function in the 
detection of mechanical signals and structurally link the extracellular matrix 
contact (ECM) to the cytoskeleton (Abercrombie and Dunn, 1975; Burridge and 
Chrzanowska-Wodnicka, 1996; Geiger and Bershadsky, 2001; Geiger and 
Bershadsky, 2002).  FA’s are formed in clusters at the cell periphery and 
composed primarily of ECM-binding integrins, but also contain bundles of actin 
stress fibers, structural proteins and cytoplasmic associated signaling proteins 
(Hynes, 1992).  Integrins are large, heterodimeric transmembrane proteins 
composed of varying α and β subunits and classified into families by their β 
subunit (Hynes, 1992).  Integrins bind the ECM through their large extracellular 
domain, while most of the small intracellular domains bind FA associated 
proteins (Liu et al., 2000).  Integrins are uniquely suited to play a structural and 
signaling role in bone cells.  It was demonstrated, using RGD peptides to disturb 
integrin-ECM interactions, that integrins play a significant signaling role in 
osteoblasts in response to oscillatory fluid shear stress (OFSS) (Ponik and 
Pavalko, 2004). 
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 Disruption of integrin-ECM interactions caused Cox-2 protein levels and 
PGE2 secretion to decrease in response to OFSS.  Since integrins do not contain 
any intrinsic kinase activity they rely on other signaling molecules, including 
adhesion-associated proteins, to convey mechanical signals to the nucleus 
(Alahari et al., 2002; Burridge and Chrzanowska-Wodnicka, 1996).  While 
integrins are the main protein in the FA site, other membrane proteins localize to 
FA’s including glycosaminoglycan receptors (Bono et al., 2001; Borowsky and 
Hynes, 1998), dystroglycans (Belkin and Smalheiser, 1996), proteoglycans 
(Woods and Couchman, 1994; Zimmermann and David, 1999), and signaling 
molecules (Myohanen et al., 1993; Tang et al., 1998; Wei et al., 1999).  The type 
of integrins found in FA’s is determined by the ECM to which the cell is adhered 
(Dejana et al., 1988; Fath et al., 1989).  FA formation requires the 
transmembrane domain of integrin, but the α and β subunits of the cytoplasmic 
domains of integrins are also functionally important.  While the β subunit of the 
cytoplasmic domain targets integrins to FA sites (Geiger et al., 1992; LaFlamme 
et al., 1992), the α subunit of the cytoplasmic domain can prevent the association 
of FA’s (Briesewitz et al., 1993).  Ligand binding induces a conformational 
change in the cytoplasmic tails allowing the β cytoplasmic subunit to bind other 
FA associated proteins.  The cytoplasmic portion of integrins are involved in an 
array of functions. There functions can be classified into three categories: 
signaling proteins, actin-binding proteins, and proteins of other functions (Liu et 
al., 2000).  The importance of the α and β subunits was revealed in a study 
where point mutations were introduced in integrins that lead to the disruption of 
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cytoplasmic integrin tail mediated signaling (Hughes et al., 1996).  After the 
cytoplasmic integrin tails undergo a conformational change they are free to either 
bind directly or indirectly with FA associated proteins.  Proteins that can bind FA 
are grouped into the following categories: tyrosoine kinases, serine/threonine 
kinases, cytoskeletal proteins, modulators of small GTPases, tyrosine 
phosphatases, and other enzymes (Zamir and Geiger, 2001).  We have outlined 
how FA’s are structurally capable of supporting the association of cells to the 
ECM, next we will discuss the signaling capacity of FA’s.    
 
Cell Signaling through Focal Adhesions 
 As briefly mentioned above, one of the roles of FA’s is to participate in cell 
signaling cascades.  FA’s serve to induce signaling cascades and amplify growth 
factor signals.  Furthermore, FA’s have demonstrated the ability to signal through 
growth factor receptors and affect ion channel activation (Miyamoto et al., 1995; 
Moro et al., 1998).  Studies have shown that FA’s and ECM proteins both 
reorganize in response to fluid shear stress (Davies et al., 1994; Pavalko et al., 
1998a).  Many signaling molecules associate with FA’s and are responsible for 
activating downstream signaling cascades.  Signaling proteins including p130Cas 
(Nojima et al., 1995; Polte and Hanks, 1995; Vuori and Ruoslahti, 1995), integrin 
linked kinase (ILK) (Li et al., 1999; Tu et al., 1999), paxillin (Burridge et al., 1992), 
zyxin (Reinhard et al., 1995), phosphoinosotide-3 kinase (PI-3K) (Chen and 
Guan, 1994), focal adhesion kinase (FAK) (Hanks et al., 1992; Schaller et al., 
1992), and Src (Nigg et al., 1982; Rohrschneider, 1980) localized to FA’s. 
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 FAK is a widely studied adhesion-associated protein found FA.  A non-
receptor tyrosine kinase, FAK, is the principal kinase in FA’s and responds to the 
clustering of integrins or adhesion (Burridge et al., 1992; Guan and Shalloway, 
1992; Kornberg et al., 1992; Lipfert et al., 1992).  Additionally, our group and 
others have also shown that FAK is activated in response to mechanical stimuli 
or fluid shear stress (Ishida et al., 1996; Li et al., 1997; Takai et al., 2006; Young 
et al., 2009).  Upon activation FAK autophosphorylates at tyrosine 397 (Calalb et 
al., 1995), exposing binding sites for Src and Fyn, which in turn phosphorylate 
additional sites on FAK and result in increased FAK activity (Schaller et al., 
1994a; Xing et al., 1994).  Additionally, the activation of FAK also exposes 
binding sites for PI3-K, paxillin, talin, and p130Cas.  FAK’s activation and 
association with these signaling molecules initiates the PI3-K pathway, ERK-
pathway, and the c-Jun NH2-terminal kinase (JNK)-pathways (Schaller et al., 
1992).  Therefore FAK, through its association with other signaling molecules, 
has an effect on cell cycle progression, early-gene expression, and apoptosis 
(Clark and Brugge, 1995; Schwartz et al., 1995).  Moreover, Src can 
phosphorylate FAK at Y576 and Y577, leading to increased FAK activity 
(Schlaepfer and Hunter, 1996).  We have reported FAK to be crucial for OFSS-
induced mechanotransduction in osteoblasts (Young et al., 2009).  Osteoblasts 
lacking FAK fail to show either early (5-30 minutes) or mid-late responses (2-24 
hours) to mechanical stimulation.  Two less understood signaling components of 
FA signaling in response to fluid shear stress are proline-rich tyrosine kinase 2 
(Pyk2) and Src. 
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 Proline-rich tyrosine kinase 2 
 Pyk2 is a closely related family member to FAK, sharing approximatly 45% 
sequence identity (Herzog et al., 1996; Inazawa et al., 1996).  Both FAK and 
Pyk2 contain an N-terminal 4.1, ezrin, radixin, moesin (FERM) domain, three 
proline-rich regions, a kinase domain, and a C-terminal focal adhesion targeting  
(FAT) domain (Figure 2) (Ceccarelli et al., 2006; Hayashi et al., 2002; 
Hiregowdara et al., 1997; Schaller et al., 1992; Schlaepfer et al., 1999).  While 
structurally similar, there are important differences between FAK and Pyk2.  FAK 
is widely expressed across many cell types, while Pyk2 is highly expressed 
primarily in brain cells, fibroblasts, platelets, and bone cells.  Interestingly, FAK 
null cells overexpress Pyk2 in what appears to be a compensatory mechanism 
(Lim et al., 2008b; Sieg et al., 1998; Weis et al., 2008).  FAK is principally 
activated through its interaction with integrins at sites of FA, but Pyk2 can also be 
activated through increases in intracellular calcium (Astier et al., 1997; Avraham 
et al., 2000; Lev et al., 1995; Tokiwa et al., 1996).  Finally, the intracellular 
distribution of Pyk2 differs from FAK.  While both are found to associate with 
integrins at sites of FA, Pyk2 is more evenly distributed throughout the cell and 
often found to be concentrated in the perinuclear region (Klingbeil et al., 2001; 
Schaller and Sasaki, 1997).  Pyk2, similar to FAK, is autophosphorylated at 
Y402, which leads to association with Src and focal adhesions (Figure 2).  Unlike 
FAK, Pyk2 can interact with and phosphorylate paxillin, a focal adhesion-
associated protein (Hiregowdara et al., 1997; Schlaepfer et al., 1999). 
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Figure 2. Pyk2’s Binding Domains and Important Phosphorylation Sites 
 
 
Pyk2 contains three distinct domains that meditate protein-protein 
interactions.  Pyk2’s FERM domain contains both a nuclear export sequence 
(NES) and a nuclear localization sequence (NLS).  Pyk2’s activation depends on 
autophosphorylation at tyrosine 402 (Y402), which then allows Src to bind Pyk2 
via its SH2 domain.  The kinase domain of Pyk2 has a second NES and two 
tyrosine sites for Pyk2’s inactivation (Y579, Y580).  Three proline rich (PR) 
regions span Pyk2.  PR2 and PR3 mediated the assocation of Pyk2 with 
p130Cas, while the focal adhesion targeting (FAT) domain mediates the 
interaction of paxillin, Hic-5, and MBD2 with Pyk2. 
 
 
 
 
 
 
 
 
 
	  23 
	  
 In bone, Pyk2 is involved in remodeling (Avraham et al., 2000; Boutahar et 
al., 2004; Gil-Henn et al., 2007; Guignandon et al., 2006; Hall et al., 2011). 
Global Pyk2 knockout mice exhibit a phenotype charaterzied by elevated bone 
mass (Gil-Henn et al., 2007; Okigaki et al., 2003).  There is a controversy in the 
bone field as to the reasons for the high bone mass phenotype.  One report 
indicates the phenotype results from defective osteoclast function implicating 
Pyk2’s role in osteoclast driven bone resorption (Gil-Henn et al., 2007), while 
another contends it is a result of increased osteoblast differentiation (Buckbinder 
et al., 2007).  As previously reviewed, Pyk2’s more well-known family member, 
FAK, serves as an important positive regulator of mechanical stimuli in 
osteoblasts (Young et al., 2009).  Pyk2’s role in mediating the response of bone 
cells to mechanotransduction is less well known, but is suggested to be different 
than FAK’s (Young et al., 2011). Additionally, reciprocal phosphorylations occur, 
with Src phosphorylating both FAK and Pyk2, while FAK and Pyk2 also associate 
and phosphorylate Src (Calalb et al., 1995; Frame et al., 2002; Schaller et al., 
1994a; Xing et al., 1994).  Unknown is whether Src is dependent on FAK and/or 
Pyk2 to transmit intracellular signals in response to mechanical loading.  While 
FAK and Pyk2 are in prime position to relay signals from the external enviroment 
to bone cells, recent studies have proposed a role for FAK and Pyk2 in the 
nucleus.  For example, it was reported that FAK and Pyk2 may play a direct role 
in regulating gene transcription in muscle and nerve cells, respectivley (Luo et 
al., 2009; Mei and Xiong, 2010).  Methyl-CpG binding domain protein 2 (MBD2) 
was found to associate with FAK through the N-terminal region of MBD2 and the 
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C-terminal focal adhesion-targeting domain of FAK (Luo et al., 2009; Mei and 
Xiong, 2010).  Their interaction promotes regulation of myogenin expression and 
differentiation in muscle cells (Luo et al., 2009; Mei and Xiong, 2010).  These 
reports suggest MBD2 binds either FAK or Pyk2 in the nucleus to effect target 
gene transcription, indicating that MBD2 might be a component of a 
mechanosome containing Pyk2 and/or Src kinase.  MBD2 is a family member of 
the methyl CpG-binding domain containing proteins, which functions to suppress 
gene transcription (Wade, 2001).  MBD2 aids in repressing transcription within 
the methyl-CpG binding protein, MBD1) MeCP1 complex (Bird and Wolffe, 1999; 
Leonhardt and Cardoso, 2000).  MBD2 interacts with heterochromatin by its 
association with methylated DNA at CpG islands. MBD2 then recruits silencing 
complexes and histone deacetylases (HDAC), resulting in condensed 
heterochromatin (Bird and Wolffe, 1999; Boeke et al., 2000; Hendrich and Bird, 
1998; Ng et al., 1999).  Undetermined is the interaction of Pyk2 or Src with MBD2 
in response to fluid shear stress and the target genes of such a mechanosome. 
  
Src Kinase  
 As briefly described above, Src is involved in integrin-mediated signaling, 
but it also participates in numerous signaling cascades and cellular functions 
including growth, movement, differentiation and cell adhesion (Brown and 
Cooper, 1996; Thomas and Brugge, 1997).  A broad range of substrates have 
been shown to be tyrosine phosphorylated by Src, including platelet-derived 
growth factor, epidermal growth factor, macrophage colony stimulating factor 1, 
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FAK, Pyk2, and vinculin (Hunter and Cooper, 1985; Parsons and Parsons, 1997).  
Src is broadly expressed in many different cell types and it is localized to different 
subcellular domains.  A member of the Src family of nonreceptor tyrosine 
kinases, Src is one of nine family members including Fyn, Yes, Frk, Blk, Fgr, 
Hck, Lck, and Lyn (Parsons and Parsons, 2004).  The Src family kinases share 
similar structural features that include Src homology (SH) domains (Boggon and 
Eck, 2004).  Specifically, Src kinase is made up for four different SH domains 
(Figure 3).  Src is localized to the plasma membrane where it participates in the 
integrin-mediated signaling response via an N-terminal myristoylation site 
(Boggon and Eck, 2004; Resh, 1994).  Src switches between a myristoylated and 
nonmyristolated form through the use of a hydrophobic pocket in the SH1 kinase 
domain (Cowan-Jacob et al., 2005).  Additionally, the SH4 domain of Src is 
required for membrane attachment. Src’s SH3 and SH2 domains are responsible 
for mediating intramolecular and intermolecular binding partners that regulate 
both Src kinase activity and signaling cascades (Figure 3) (Koch et al., 1991; 
Pawson, 1988; Pawson and Gish, 1992).  The SH3 domain binds many FA-
associated proteins including integrins (Arias-Salgado et al., 2003), paxillin 
(Weng et al., 1993), and p130Cas (Nojima et al., 1995).  The SH2 domain is 
highly conserved and mediates many protein-protein interactions including FAK 
and Pyk2 (Pawson and Nash, 2003; Schaller et al., 1994b).  The SH1 domain is 
the cataylictic or kinase domain within Src.  To control the specific binding of 
Src’s numerous partners Src has two distinct conformations.  For full catalytic 
activity of Src, autophosphorylation occurs at tyrosine 418 (Y418) within the  
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Figure 3. Src’s Binding Domains and Important Phosphorylation Sites 
 
Src mediates many of its protein-protein interactions via SH domains.  Src 
contains an N-terminal myristolation sites for anchoring itself in plasma 
membrane.  The SH3 and SH2 domains mediate the binding of FA-associated 
proteins, including p130Cas, integrins, vinculin, Pyk2, and FAK.  The SH1 
domain, also known as the kinase domain, contains Src’s phosphorylation site 
(Y418) for activation within the activation loop.  A C-terminal inhibition site is 
found at tyrosine 527. 
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activation loop of the SH1 domain (Smart et al., 1981).  In an active confirmation, 
the SH2 and SH3 domains are readily accessible for substrate binding.  When 
Src is in an inactive state the autoinhibitor phosphorylation site (Y527) in the C-
terminal tail is phosphorylated (Cooper et al., 1986) and the SH2, SH3, and SH1 
domains bind to one another to form an autoinhibited conformation (Sicheri and 
Kuriyan, 1997; Williams et al., 1997; Xu et al., 1997).  C-terminal Src kinase 
(Nada et al., 1991) and CSK-homologous kinase (Davidson et al., 1997; 
Hamaguchi et al., 1996) usually carry out the inactivating phosphorylation at 
Y527.  Alternatively, protein tyrosine phosphatases including SH2 domain-
containing protein tyrosine phosphatases 1 and 2 (SHP1, SHP2) are capable of 
activating Src by dephosphorylating Y527 (Chiang and Sefton, 2001; 
Rangaswami et al., 2010). 
 In bone Src helps maintain the balance of normal bone remodeling.  Mice 
lacking Src exhibit an osteopetrotic phenotype (Soriano et al., 1991).  More 
specifically, Src null mice exhibit incisor eruption failure, thickened growth plate, 
perseverance of the endochondral primary spongiosa, reduced bone marrow 
tissue, and overall small size (Soriano et al., 1991).  The high bone mass 
phenotype of Src null mice is caused by malfunctioning osteoclasts and 
osteoblasts.  Src null mice display increased numbers of inactive osteoclasts.  
These osteoclasts lack a ruffled border; therefore they cannot attach to the 
surface of bone and promote bone resorption (Boyce et al., 1992; Horne et al., 
1992; Lowe et al., 1993).  Osteoblasts lacking Src contribute to the high bone 
mass phenotype by overexpressing Runx2, alkaline phosphatase, PTH/PTHrP, 
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and osteocalcin (Marzia et al., 2000).  Finally, as the Src null mice age their bone 
mass continues to increase.  Therefore, a loss of Src activity causes an increase 
in bone mass (Amling et al., 2000).  Recent studies of Src inhibitors have lead to 
clinical trials exploring their use for treating low bone mass (Hannon et al., 2010; 
Missbach et al., 1999), however it is imperative to understand the implications of 
Src inhibition on bone remodeling in response to mechanical loading. 
 Fluid shear stress causes an increase in Src activation in osteoblasts and 
osteocytes, as well as endothelial cells and colon cancer cells (Jalali et al., 1998; 
Okuda et al., 1999; Plotkin and Bellido, 2001; Rangaswami et al., 2010; 
Rangaswami et al., 2012; Takahashi and Berk, 1996; Thamilselvan et al., 2004).  
Due to its location and numerous binding partners, Src is in prime positioned to 
propagate cellular signals in bone cells after exposure to fluid shear stress.  The 
Pilz group has described a new pathway of Src activation in response to 
unidirectional fluid flow, in which a NO/cGMP/PKGII/SHP-1 pathway leads to Src 
activation via association with integrins (Rangaswami et al., 2010).   
 
 
In Vitro Methods to Assess Signaling in Response to Fluid Shear Stress	  
 
Bone Cell Culture Models 
Commonly, researchers have isolated primary cells to study the cellular 
properties and signaling cascades of osteoblasts.  A traditional source of primary 
osteoblasts is isolated from the calvaria of newborn mice.  Mouse calvarial 
	  29 
	  
osteoblasts (MCOB) exhibit high alkaline phosphatase expression and increase 
its activity in response to treatment with ascorbic acid and β-glycerophosphate 
(Lynch et al., 1995).  Additionally, MCOB’s respond to calcitonin and mineralize 
in culture (Binderman et al., 1974).  While MCOB’s are a phenotypically ideal 
model, primary osteoblasts can be difficult to work with in culture and their 
proliferative capacity is limited.  
 To overcome some of the limitations of MCOB, several types of bone cell 
lines have been developed to investigate bone cell physiology.  In establishing 
bone cell lines researchers wanted to develop models that mimicked important 
characteristics of primary osteoblasts and osteocytes.  For immortalized 
osteoblastic cell lines some of the sought after hallmarks included alkaline 
phosphatase activity, mineralization, expression of collagen type 1, production of 
collagenase, release of prostaglandins, responsive to parathyroid hormone and 
prostaglandin E2, and expression of the receptors for of 1,25(OH)-vitamin D3, 
parathyroid hormone and epidermal growth factor.  The cell line MC3T3 is a 
commonly used osteoblastic cell line originally derived from the calvaria of 
newborn mice (Sudo et al., 1983).  These cells can differentiate into osteoblasts 
and osteocytes, can deposit mineral into bone matrix, and express high amounts 
of alkaline phosphatase (Sudo et al., 1983).  
 The murine long bone osteocyte Y4 (MLO-Y4) was derived from a single 
colony isolation, derived from long bone mice expressing SV40 T Large antigen, 
driven by the osteocalcin promoter (Kato et al., 1997).  MLO-Y4 osteocytes 
exhibit osteocyte-like dendritic morphology, expression of connexin 43, and 
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secretion of osteocalcin.  Establishing immortalized osteoblast and osteocytes 
cells lines was an important step to enable in vitro investigations into the 
signaling mechanisms induced by fluid shear stress.  Only recently has 
successful isolation of primary osteocytes from the long bones been described 
(Stern et al., 2012).   
 
Models of Fluid Flow 
 In vivo models of mechanical loading and unloading of bone have been 
developed to study broad changes in bone in architecture, as well as, alterations 
in the microarchitecture.  Two common models include ulnar loading (Torrance et 
al., 1994) and hindlimb suspension (Morey, 1979).  To investigate changes in cell 
signaling networks in response to mechanical loading in vitro models of fluid 
shear stress have been designed.  On a cellular level, osteoblasts and 
osteocytes experience mechanical loading via pressure changes in interstitial 
fluid flow (Hillsley and Frangos, 1994).  Therefore, researchers have designed 
numerous methods for replicating the interstitial fluid shear stress experienced by 
osteoblasts and osteocytes.  
 A model of unidirectional fluid flow in a parallel plate flow chamber was 
first described by Frangoe and colleagues to study the metabolic response of 
endothelial cells to steady and pulsatile shear stresses (Frangos et al., 1988).  
The unidirectional model of fluid shear stress was used by many researchers in 
the bone field until oscillatory fluid flow models were developed, and thought to 
be more physiologically similar to the flow pattern of interstitial fluid.  Our group 
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demonstrated unidirectional and oscillatory fluid flow profiles produce different 
responses from osteoblasts and osteocytes (Ponik et al., 2007).  Oscillatory fluid 
flow is produced within parallel plate flow chambers that house a glass slide on 
which bone cells are plated.  Hard-walled tubing connects the parallel plate flow 
chamber to the oscillatory pump, which controls the adjustable flow rate (0-25 
dynes/cm2) of media across the surface of the bone cells.  The main advantage 
of using of an oscillatory pump to induce fluid shear stress is the controllable and 
uniform flow pattern that it produces across bone cells.  Three prominent 
disadvantages are the limited length (< 12 hours), non-repetitive nature of flow 
exposure and the dissimilar set-up for static samples. 
 A newer method for inducing fluid shear stress across the surface of bone 
cells uses an orbital shaking platform. Use of an orbital shaking platform 
overcomes some of the significant limitations in the experimental design of the 
parallel plate flow chamber model (Inoue et al., 2004; Kido et al., 2009; Sakai et 
al., 1999; Young et al., 2011).  Two of the major advantages of using an orbital 
shaking platform include the opportunity for long (> 24 hours) and/or intermittent 
periods of fluid flow and easier collection of static samples for analysis.  Inducing 
fluid flow via an orbital shaking platform rotating at ~200 rpm produces 
approximately 1.5-2.5 Pa (~15-25 dynes/cm2) of shear stress force at the outer 
radius of the dish.  Shear stresses toward the center of the dish are lower in 
magnitude. (Sakai et al., 1999).  While still a new method to the field of bone 
biology, the orbital shaking platform has been used in a number of studies.  
Interleukin-11 expression during osteoblast differentiation was successfully 
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examined in response to mechanical stimulation via orbital platform shaking 
(Kido et al., 2009; Sakai et al., 1999).  Additionally, orbital shaking platform 
induced fluid shear stress led to increased FosB/ΔFosB expression in 
osteoblasts (Inoue et al., 2004).  Finally, osteoblasts respond similarly to fluid 
shear stress induced by either the oscillatory pump or the orbital platform shaker 
(Young et al., 2011).  In summary, while the oscillatory pump produces oscillatory 
fluid flow and the orbital shaking platform generates dynamic fluid flow, both 
produce physiologically relevant fluid shear rates. 
 
Live Cell Imaging 
 The field of microscopy encountered a revolutionary change with the 
cloning of green florescent protein (GFP) from the jellyfish, Aequorea Victoria.  
GFP was discovered by Shimomura and collogues who noted that “a protein 
giving solutions that look slightly greenish in sunlight through only yellowish 
under tungsten lights, and exhibiting a very bright, greenish fluorescence in the 
ultraviolet of a Mineralite” (Shimomura et al., 1962).  This description of GFP is 
still correct; it is in the green portion of the visible spectrum.  The jellyfish GFP’s 
main excitation peak is at a wavelength of 395 nanometers, with a minor peak at 
475 nanometers, and emission peak at 509 nanometers (Johnson et al., 1962).  
GFP is composed of 238 amino acids and consists of eleven β-sheets with six 
alpha helices and contains a covalently bonded chromophore buried in the center 
of the cylinder (Morise et al., 1974; Prendergast and Mann, 1978).  In research, 
GFP has been used as a tracer of cell lineage, a reporter of gene expression, 
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and protein tag to monitor localization in living cells (Chalfie and Kain, 2006).  
The jellyfish GFP was limited by low brightness, complicated photoisomerization, 
near UV excitation, a substantial delay between protein synthesis and fluorescent 
development.  Mutagenesis has allowed researchers to expand the spectral 
characteristics of GFP by shifting the excitation and emission wavelengths.  The 
engineering of the jellyfish GFP, along with cloning and optimization of similar 
proteins from a variety of marine organisms, have yielded a whole spectrum of 
fluorescent proteins (FP) allowing researchers to monitor biological events. 
 The field of Förster Resonance Energy Transfer (FRET) microscopy has 
benefitted tremendously from genetically encoded FPs.  FRET is named for the 
German scientist, Theodor Förster, who first provided a quantitative 
understanding of the process (Förster, 1948).  FRET is a distance dependent 
process by which energy is directly transferred from a donor fluorophore to a 
nearby acceptor via near-field electromagnetic dipole interactions.  When FRET 
occurs the donor’s emission signal is quenched.  For efficient transfer of energy 
from donor to acceptor there are three essential requirements (Förster, 1965; 
Stryer, 1978).  First, the donor and acceptor probes must be in close proximity.  
FRET can only take place over a distance of less than 10 nanometers, making it 
a highly sensitive technique for investigating biological activities.  Second, the 
donor and acceptor dipole-dipole alignment must be favorable. Third, there must 
be significant overlap between the donor emission and acceptor excitation 
spectra.  Spectral overlap leads to spectral bleedthrough, a pitfall that must be 
corrected when detecting FRET signals.  There are two components to spectral 
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bleedthrough.  The first is the direct excitation of the acceptor at the wavelength 
used to excite the donor (acceptor cross talk).  The second is the donor emission 
that is detected in the acceptor (FRET) channel (Day and Davidson, 2012).  
When the three requirements for FRET are fulfilled quantification of FRET signals 
can offer Ångstrom level measurements of the distance between the donor and 
acceptor fluorophores within living cells. 
 There are a number of different ways of measuring FRET signals.  The 
most common methods for assessing FRET are spectral bleed-through 
correction, spectral imaging, acceptor photobleaching, and fluorescent lifetimes 
(Day and Davidson, 2012).  Spectral bleedthrough correction is a general 
computer algorithm-based method that can be applied to any type of microscopy.  
Spectral imaging of FRET signals entails acquiring a wide range of emission 
wavelengths to produce a lambda stack which allows for analysis of spectral 
characteristics of the fluorescent signal of each pixel (Dickinson et al., 2001; 
Zimmermann et al., 2003).  Spectral imaging of FRET is a specific type of 
microscopy that spectral bleedthrough correction can be applied to.  A major 
advantage of spectral imaging is that it is acquired more quickly than other 
methods.  Acceptor photobleaching measures the quenched donor population 
first, and then the acceptor fluorophores are deliberately photobleached, 
eliminating them from participating in the FRET process (Bastiaens et al., 1996; 
Day et al., 2001; Kenworthy, 2001).  Removing the acceptor fluorophore causes 
the donor molecule to dequench, increasing the fluorescence emission from the 
donor.  Importantly, after photobleaching the acceptor is not susceptible to 
	  35 
	  
spectral bleed-through due to the elimination of the acceptor’s participation in the 
FRET process.  Since photobleaching is not reversible it is an approach that 
limits the possibility for dynamic FRET measurements.  Lastly, measuring the 
changes in donor fluorescent lifetimes is another method for measuring FRET 
(Periasamy and Clegg, 2009).  Fluorescent lifetime is the average time a 
molecule spends in the excited-state before relaxing down to the ground state.  It 
is a fundamental property of a fluorophore and range between one to ten 
nanoseconds.  When measuring donor fluorescent lifetimes, spatial distribution of 
the lifetimes can be mapped using Fluorescence Lifetime Imaging Microscopy 
(FLIM).  A major advantage to this method is that lifetime measurements are 
independent of deviations in the probe concentration and excitation intensity.  
 FLIM can be analyzed by two different approaches, time domain and 
frequency domain (Clegg, 2010).  A pulsed-light source is used to excite a 
fluorophore in the time domain method and then the emission photons are 
collected at various time points.  This information is used to produce a 
fluorescence decay profile that estimates the fluorescent lifetime.  The frequency 
domain method uses a high frequency modulated light source to excite the 
fluorophores.  Depending on the lifetime of the fluorophores, a modulation 
frequency is chosen often between 20-140 megahertz.  Changes in the phase 
and amplitude of the emission signal are compared to the excitation source to 
extract the fluorophore’s fluorescence lifetime.  A major advantage to using FLIM 
to assess FRET is that the measurements are made in the donor channel, which 
is usually unaffected by spectral bleed-through.  FLIM is suitable for visualizing 
	  36 
	  
probes that indicate changes such as ion concentration, post-translational 
modifications or pH.  Fluorescent lifetime are sensitive to their environment and 
would not be appropriate for fixed specimens.  Rapid changes in FRET signals 
(less than a minute) may be missed by the time it takes to acquire fluorescent 
lifetimes. 
  Experimentally, there are two forms of FRET, intermolecular and 
intramolecular.  Intermolecular FRET occurs between independent donor 
fluorophore and acceptor molecule (Figure 4).  For example, intermolecular 
FRET could occur between two different proteins, one labeled with a donor 
fluorophore and one with an acceptor.  Intramolecular FRET occurs between a 
donor fluorophore and acceptor on the same molecule.  Commonly, biosensors 
are examples of intramolecular FRET.  A biosensor usually contains a donor and 
acceptor fluorophore, along with a phosphorylation substrate used to monitor 
dynamic changes in kinase activity.  For instance, a conformational change 
within the molecule could cause the fluorophores to move away from one 
another, diminishing a FRET event.  The first biosensor was the cyclic AMP 
(cAMP) biosensor, which was a genetically encoded sensor of activities mediated 
by cAMP (Adams et al., 1991). Interesting, the first version of the cAMP 
biosensor contained organic dyes, rather than fluorophores, which were attached 
to the catalytic and regulatory subunits of cAMP (Adams et al., 1991).  Other 
examples of FRET biosensors used by investigators include GTPases 
(Nakamura et al., 2005), second messengers (Herbst et al., 2009), protein 
kinases (Herbst et al., 2009), and membrane receptors (Lohse et al., 2007).   
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Figure 4. Intermolecular and Intramolecular FRET 
 
Schematic examples of intermolecular and intramolecular FRET.  (A) 
Example of intermolecular FRET.  The donor (blue) fluorophore is fused with a 
protein (orange) that finds a binding partner in a different protein (red) that is 
fused to an acceptor fluorophore (green).  When the two proteins (orange and 
red) are bound, a FRET event occurs between the two fluorophores resulting in 
quenched emission of the donor.  (B) Example of intramolecular FRET.  The 
donor (blue) fluorophore and acceptor fluorophore (green) are on the same 
molecule, usually connected through a short amino acid linker.  Figure is adapted 
from Hum, et al., 2012. 
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Interestingly many FRET biosensors have been developed to monitor enzymatic 
modifications, such as protein ubiquitination (Perroy et al., 2004), acetylataion 
(Sasaki et al., 2009), O-glycosylation (Carrillo et al., 2006), histone methylation 
(Lin et al., 2004), and phosphorylation/dephosphorylation (Newman and Zhang, 
2008; Ni et al., 2006).  Kinase activation/activity is a heavily utilized category of 
FRET biosensors (Ni et al., 2006; Zhang and Allen, 2007).  Recently, a RhoA 
biosensor was utilized to monitor RhoA activation in osteoblasts in response to 1 
hour of fluid shear stress (Hamamura et al., 2012).  A Src biosensor was capable 
of detecting an increase in Src activity in response to mechanical stimulation in 
endothelial cells (Wang et al., 2005).  A combination of Src and FAK biosensors 
were used to demonstrate that Src activity decreases and FAK activity increases 
during differentiation of human mesenchymal stem cells (Liao et al., 2012).  The 
field of signal transduction requires tools for tracking the dynamic nature of 
signaling molecules.  FRET biosensors can serve this need and are an exciting 
tool that permits monitoring molecules with great spatiotemporal resolution in 
their native cellular environment. 
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Thesis Hypothesis and Specific Aims 
 Based on the research findings summarized above and the current lack of 
understanding of the molecular mechanisms that curb the response of bone to 
mechanical loading, the following central hypothesis was formulated: “STOP” 
mechanosomes exist to actively suppress the anabolic response of osteoblasts 
and osteocytes to fluid shear stress.  This hypothesis was tested by examining 
two specific aims: 1) Determine Src’s ability to function as a “STOP” 
mechanosome in osteoblasts and osteocytes and 2) Characterize the role of 
Pyk2 in response to fluid shear stress in osteoblasts and osteocytes. 
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Chapter II 
 
MATERIALS AND METHODS 
 
Cell Culture Conditions.  MC3T3 osteoblasts, mouse calvarial osteoblasts 
(MCOB), and Pyk2 -/- osteoblasts were cultured in minimal essential media alpha 
(MEM-α, Gibco, Life Technologies, Carlsbad, CA) containing 10% fetal calf 
serum (FCS) and 1% penicillin/streptomycin (Gibco, Life Technologies, Grand 
Island, NY).  MLO-Y4 osteocytes were cultured on collagen-coated plates (rat tail 
collagen type I, BD Biosciences, San Jose, CA) in MEM-α (Gibco, Life 
Technologies, Carlsbad, CA) supplemented with 5% FCS, 5% fetal bovine serum 
(FBS) and 1% penicillin/streptomycin (Gibco, Life Technologies, Grand Island, 
NY). Cells were maintained in 5% CO2 at 37° C during experiments and imaging.  
 
Fluid Flow Conditions.  Two methods were used to induce fluid shear stress 
over the surface of cells.  An oscillatory pump connected to parallel plate flow 
chambers via hard–walled tubing was used to induce a shear rate of 10 
dynes/cm2 across the surface of cells plated on glass slides.  Additionally, a 
reservoir was created for the movement of fluid and 5% CO2 exchange using 
hard-walled tubing attached to the outlet of the parallel plate.  Static controls 
were incubated in the same volume of media.  Prior to exposure to fluid flow, 
cells were serum starved (MEM-α, 0.5% FCS) overnight.  During fluid flow 
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experiments the parallel plate flow chambers and attached hard-walled tubing 
were placed in an incubator set to 37°C and 5% CO2. 
 Similarly, an orbital shaking platform was used to induce fluid flow over the 
surface of MC3T3 osteoblasts and MLO-Y4 osteocytes.  Cells plated in 6 well 
culture dishes were placed on an orbital shaking platform within an tissue culture 
incubator set to 37°C and 5% CO2.  Prior to experimentation, cells were grown 
overnight in low-serum α-MEM media supplemented with 0.5% FCS and 
antibiotics. Cells were subjected to fluid flow generated by 1 mL of media on an 
orbital platform shaker rotating at a speed of ~200 rpm (2Hz) producing a 
estimated shear rate of ~10-25 dynes/cm2 while inside a tissue culture incubator 
(Inoue et al., 2004; Kido et al., 2009; Sakai et al., 1999; Young et al., 2011).   
 
Src Inhibitor. MC3T3 osteoblasts and MLO-Y4 osteocytes were treated with Src 
Inhibitor 1 (Santa Cruz Biotechnology, Santa Cruz, CA) (10µM) for 1 hour before 
experiments were conducted. Control samples were treated with equal volume of 
DMSO.  
 
Western Blotting Analysis. Cells exposed to static or flow conditions were 
harvested directly into SDS sample buffer and protein concentrations were 
determined using amino black method (Sheffield et al., 1987).  Equal amounts of 
protein were loaded onto SDS-PAGE gels for separation and transferred to 
nitrocellulose.  The subsequent primary and secondary antibodies were used: 
phospho-Src (Y418) (Cell Signaling, Boston, MA), total Src (Cell Signaling, 
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Boston, MA), γ-tubulin (Sigma-Aldrich, St. Louis, MO), lamin B (Santa Cruz, 
Santa Cruz, CA), HRP conjugated goat anti-rabbit and HRP conjugated goat 
anti-mouse (Jackson Immunoresearch, West Grove, PA).  The secondary 
antibody signals were detected using a Luminescent Image Analyzer LAS-3000 
system (Fujifilm Life Science, Stamford, CT). Densitometry was quantified using 
Image J software (NIH). 
 
RNA Extraction, cDNA Synthesis and quantitative real-time PCR (qRT-PCR) 
Analysis.  RNA was harvested from cultured MC3T3 osteoblasts and MLO-Y4 
osteocytes in Trizol (Invitrogen, Carlsbad, CA).  RNA was extracted with 
chloroform and precipitated with isopropanol.  M-MLV reverse transcriptase 
(Promega, Madison, WI) was used to perform first strand cDNA synthesis. 
GAPDH (Mm99999915_g1), osteopontin (Mm00436767_m1), and RPLP2 
(Mm03059047_gH) real-time PCR primers were obtained (Applied Biosystems, 
Grand Island, NY). Custom designed primer/probes were prepared for 
osteocalcin. (forward) 5(-CTGACAAAGCCTTCATGTCCAA-)3 (probe) 5(-
AGGAGGGCAATAAGGTAGT-)3 and (reverse) 5(-
GGTAGCGCCGGAGTCTGTT-)3.  TaqMan Universal PCR Master Mix (Applied 
Biosystems, Grand Island, NY) was used for amplification in a Mastercycler ep 
realplex2 real-time PCR system (Eppendorf, Westbury, NY).  The reaction 
conditions were as follows: 2 minutes at 50°C; 10 minutes at 95°C; 40 cycles of 
15 seconds at 95°C and 1 minute at 60°C.  The ΔΔCT method was used to 
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evaluate gene expression between samples. RPLP2 and GAPDH were used as 
a loading control genes. 
Immunofluorescence. Images for all experiments were captured using a Nikon 
inverted immunofluorescence microscope equipped with a CCD camera.  MLO-
Y4 osteocytes cells were plated onto coverslips and placed into 6 well culture 
dishes.  Cells were serum starved for 24 hrs (0.5% FCS), subjected to static 
conditions and fixed immediately or fixed after 20 minutes of OFSS (via orbital 
shaking platform) with 4% paraformaldehyde solution and permeablilized with 
0.2% triton after rising with Tris-buffered saline (TBS).  Coverslips were treated 
with normal donkey serum for 30 minutes at 37°C to block non-specific antibody 
binding.  The following primary and secondary antibodies were used: Src and Src 
Y418 (Cell Signaling, Boston, MA) followed by FITC-conjugated donkey anti-
rabbit (Jackson Immunoresearch, West Grove, PA).  Texas-Red phalloidin and 
DAPI (Molecular Probes, Eugene, OR) were used for visualizing F-actin and the 
nucleus, respectively. 
 MCOB were plated on glass coverslips, ~2.0 x105 cells per slide (~1.1 
x105 cells/ cm2), following 24 hrs of serum starvation (0.5% FCS), cells subjected 
to static culture conditions were fixed immediately (static) or fixed after OFSS (30 
minutes, 1 hour, or 1 hour plus 1 hour) (via oscillatory pump) with 4% 
paraformaldehyde solution and processed for immunofluorescence by 
permeabilization with 0.2% triton followed by rinsing in Tris-buffered saline (TBS). 
Slides were then treated with 1% BSA solution in TBS for 30 minutes at 37°C to 
block non-specific antibody binding. The following primary and secondary 
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antibodies were used: Pyk2 (BD Biosciences, San Jose, CA), DAPI (Molecular 
Probes, Eugene, OR), and FITC-conjugated donkey anti-rabbit (Jackson 
Immunoresearch, West Grove, PA). 
 
DNA Plasmids. The Src biosensor and Src mutant biosensor were generously 
obtained from Dr. Yingxiao Wang (Wang et al., 2005).  
 
FRET Microscopy. One day prior to imaging, MLO-Y4 cells were electroporated 
(150V, 9ms) with either the Src biosensor or the Src mutant biosensor (10µg).  
Cells were plated into 35mm glass bottom dishes (MatTech, Ashland, MA) and 
maintained in phenol-free, MEM-α media supplemented with 0.5% FCS and 
antibiotics.  The following day, FRET microscopy was performed using an ISS 
ALBA FastFLIM system (ISS Inc., Champagne, IL) coupled to an Olympus IX71 
microscope equipped with a 60 X / 1.2 NA water-immersion objective lens.  A 
5mW 448 nm diode laser was modulated by the FastFLIM module of the ALBA 
system at a fundamental frequency of 20 MHz with up to six sinusoidal 
harmonics.  The modulated 5mW 448 nm laser was used to excite the donor 
fluorophore of either the Src biosensor or Src mutant biosensor. The frequency 
domain FLIM method was used to obtain fluorescent lifetime(s) based on 
emission signal changes in the phase and amplitude compared to the excitation 
source. The phasor plots, lifetime maps and intensity images were analyzed 
using ISS VistaVision software (ISS Inc., Champagne, IL).  Lifetime maps were 
generated using a two-component fit for the calculation of the donor lifetime.  The 
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phasor plots display the modulation and phase characteristics of the emission 
signal for every pixel in an image, generating a visual determination of the 
lifetime (Jameson et al., 1984; Redford and Clegg, 2005).  Lifetime data from 
MLO-Y4 cells were extracted from three different regions of interest (ROI): 
plasma membrane, cytoplasm and nucleus. Bodipy C12 (Invitrogen Corp., Grand 
Island, NY) (0.01mg/mL) was used to stain the plasma membrane and outline the 
nucleus.   
 
Nuclear Fractionation.  Cells subjected to either static or OFSS treatment in 6 
well dishes were washed with phosphate buffered saline, harvested in ice-cold 
hypotonic buffer (10mM HEPES, 10mM KCL, 1.5mM MgCl2, 1mM DTT and 
protease inhibitors), passed through a 22-gauge needle five times and were 
centrifuged for 10 minutes at 13,000 rpm. The cytosolic fraction was saved while 
the nuclear fraction pellet was resuspended in buffer C (10mM HEPES, 0.42 M 
NaCl, 25% Glycerol, 1.5mM MgCl2, 0.5mD EDTA, ddH2O and protease 
inhibitors) placed on ice and vortexed for 15 seconds every 10 minutes for an 
hour to swell nuclear proteins out the nuclei.  Finally the samples were 
centrifuged at 4°C for 15 minutes at 14,000 rpm. The clear supernatant was 
collected and prepared for western blot analysis.  
 
Immunoprecipitation.  For detecting protein-protein interactions in vivo co-
immunoprecipitation was performed in MC3T3 osteoblasts and MLO-Y4 
osteocytes.  Immunoprecipitation was performed using Src protein, Src (Y416), 
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MBD2, normal rabbit serum, or normal mouse serum.  Immunoprecipitation 
buffer contained 1% Triton-X-100, 145 mM NaCl, 10mM Tric-Cl, pH 7.4, 5mM 
EDTA, 2mM EGTA, and 1mM PMSF.  Immune complexes were captured using 
Protein A sepharose beads (Sigma-Aldrich, Saint Louis, MO) conjugated to either 
goat-anti rabbit or goat-anti mouse antibody (Jackson Immunoresearch 
Laboratories, West Grove, PA). 
 
Statistical Analysis.  Statistical significance was assessed by either a two-tailed 
t-test or a two-way analysis of variance (ANOVA) with a p-value of p<0.05 or less 
interpreted as statistically significant. 
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Chapter III 
Nuclear Src Activity Functions to Suppress the Anabolic Response 
Osteoblasts and Osteocytes to Fluid Shear Stress 
ABSTRACT 
  Global deletion of Src kinase from mice results in increased bone mass.  
We tested the novel hypothesis that Src plays a previously unrecognized role in 
bone formation by regulating gene expression in osteoblasts and osteocytes, 
particularly in response to mechanical loading.  Inhibition of Src activity using a 
pharmacologic inhibitor in MC3T3 osteoblasts and MLO-Y4 osteocytes led to an 
increase in expression of the anabolic bone gene osteocalcin.  Mechanical 
stimulation of MC3T3 osteoblasts and MLO-Y4 osteocytes by fluid shear stress 
further enhanced expression of osteocalcin when Src activity was inhibited.  
Importantly, using a Src biosensor and nuclear fractionation, we report for the first 
time that Src activity in the nucleus increased in response to fluid shear stress.  
This study supports the idea that Src plays a nuclear role, suppressing expression 
of osteocalcin via a previously unrecognized function that limits the anabolic 
response of osteoblasts and osteocytes to fluid shear stress. 
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INTRODUCTION 
 
 Global disruption of Src, a 60 kDa non-receptor tyrosine kinase, resulted 
in a mouse with a high bone mass phenotype, demonstrating the importance of 
Src in bone remodeling (Soriano et al., 1991).  The function of both osteoclasts 
and osteoblasts is altered in Src-/- mice (Marzia et al., 2000; Soriano et al., 
1991).  Osteoclast numbers are increased at the bone surface, but lack a ruffled 
border and are inactive (Boyce et al., 1992; Horne et al., 1992; Lowe et al., 
1993). Accelerated osteoblastogenesis was observed in the Src-null mice, 
suggesting Src activity plays a suppressive role in osteoblast differentiation 
(Amling et al., 2000; Marzia et al., 2000).  These findings led to studies focused 
on producing a Src inhibitor to treat osteoporosis (Hannon et al., 2010; Hannon 
et al., 2012; Id Boufker et al., 2010; Missbach et al., 1999).  
 If Src functions to balance bone mass by suppressing anabolic bone genes, it is 
also likely to affect the response of bone to mechanical loading.  In the healthy 
mammalian skeleton, this process is mediated by osteocytes and osteoblasts that 
coordinate an appropriate response to mechanical loading resulting in localized 
net bone gain or loss depending on the type of load experienced at specific sites 
(Miller et al., 2007; Nicolella et al., 2008; Robling, 2009).  Osteocytes and 
osteoblasts sense and react to mechanical loads generated by the fluid flow 
through the canalicular system within bone (Buss et al., 1986; Montgomery et al., 
1988; Resh, 1994).  In vitro, osteoblasts and osteocytes respond to mechanical 
load simulated via the application of oscillatory fluid shear stress (OFSS).  Fluid 
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shear stress causes distortions of the membranes of osteoblasts and osteocytes 
resulting in the enhanced expression of genes associated with osteoblast activity, 
up regulating cell proliferation and increasing the release of paracrine factors 
required for bones to elicit an anabolic response (Knothe Tate et al., 1998; Smalt 
et al., 1997; Turner and Pavalko, 1998).  Src also becomes activated in response 
to OFSS in osteoblasts and osteocytes (Plotkin et al., 2005; Rangaswami et al., 
2010; Rangaswami et al., 2012).  The Pilz group recently suggested that Src 
plays an integral role in relaying mechanical messages in osteoblasts via NO-
cGMP-PKG signaling resulting in a proliferative response (Rangaswami et al., 
2010).  Additionally, this group described the convergence of PKG and FAK on 
the Src/Akt/β-catenin signaling pathway during osteoblast mechanotransduction 
(Rangaswami et al., 2012).  While Src is activated in osteoblasts and osteocytes 
in response to OFSS, the impact of Src activation on gene transcription under 
conditions of OFSS is unclear. 
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RESULTS  
 
Src kinase represses osteocalcin in static and OFSS conditions  
 To evaluate the role of Src in basal expression of osteogenic genes in 
MC3T3 osteoblasts and MLO-Y4 osteocytes we treated cells with a 
pharmacologic inhibitor of Src activity (Src inhibitor-1, SI1). We first confirmed 
that SI1 effectively inhibited Src activity by showing that SI1 inhibited fluid flow-
induced Akt phosphorylation (Figure 5).   To assess OFSS-induced changes in 
gene expression we utilized real-time quantitative PCR (qRT-PCR) analysis of 
mRNA (primers listed in Table 2).  Osteocalcin expression significantly increased 
in both MC3T3 osteoblasts and MLO-Y4 osteocytes treated with SI1. (Figure 6).  
Most importantly, OFSS further enhanced the express of osteocalcin in both 
MC3T3 osteoblasts and MLO-Y4 osteocytes treated with SI1 compared to static 
controls treated with carrier (DMSO) only (2.7 and 3.4 fold change, respectively; 
Figure 7).   
 
Activated Src (Y418) accumulates in perinuclear and nuclear regions in 
response to OFSS  
 To determine whether Src may affect OFSS-induced transcription via an 
increase in tyrosine kinase activity in the nucleus, we first examined the total 
cellular distribution of Src in MLO-Y4 osteocytes in response to OFSS.  
Immunofluorescence microscopy indicated a shift in the distribution of both total 
Src and activated Src (as assessed by phosphorylation at tyrosine residue Y418) 
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following 20 minutes of exposure to OFSS.   Using an antibody that recognizes 
only activated Src phosphorylated at tyrosine 416 (Y418) we found that activated 
Src accumulated in the perinuclear/nuclear area of MLO-Y4 osteocytes after 
exposure to OFSS (Figure 8A, white arrows highlight areas of FA).  Total Src 
protein also increased modestly in the perinuclear/nuclear regions after OFSS, 
but was not as pronounced as that of the activated (Y418) Src (compare Figures 
8A and 8B).  This suggests that Src activation by phosphorylation at Y418 may 
be required for Src to accumulate in this region of the cell. 
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Figure 5. Treatment with Src inhibitor 1 Prevents Src Activity in 
Response of OFSS 
 
 
 
 
 
 
 
 
One hour of Src inhibitor 1 (SI1) treatment prevents Src kinase activity.  
MC3T3 osteoblasts and MLO-Y4 osteocytes were plated at a density of 1.0  x 
105 into 6 well dishes and serum starved in MEM-α (5% FBS) overnight.  Cells 
were treated with 10µM SI1 for 1 hour prior to 1 hour of OFSS. Western blot 
analysis of phosphorylated-Akt (Ser308), Total Akt, and γ-tubulin under static and 
OFSS conditions (1 hour).  
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Figure 6. Osteocalcin Expression in MC3T3 Osteoblasts and MLO-Y4 
Osteocytes Treated with SI1  
 
Inhibiting Src kinase activity causes an increase in basal levels of 
osteocalcin expression.  MC3T3 osteoblast and MLO-Y4 osteocytes were 
plated in 6 well dishes and treated with either control (DMSO) or SI1 (10µM) for 
one hour.  SI1 treatment significantly increases the expression of osteocalcin in 
MC3T3 osteoblasts and MLO-Y4 osteocytes.  *Represents a statically significant 
increase compared to static control (*p<0.05).  Error bars represent standard 
error.  An n > 3 was used and experiments were performed in triplicate. 
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Figure 7. OFSS-induced Osteocalcin Expression in MC3T3 Osteoblasts 
and MLO-Y4 Osteocytes Treated with SI1  
 
OFSS further enhanced the expression of osteocalcin in both MC3T3 
osteoblasts and MLO-Y4 osteocytes compared to static controls. MC3T3 
osteoblasts and MLO-Y4 osteocytes were treated with either control (DMSO) or 
SI1 (10µM) for 1 hour prior to exposure to either static of OFSS conditions. 
(p<0.05). *Represents a statically significant increase compared to static control 
(*p<0.05). #Represents a statically significant difference between treatment 
groups (#p<0.05) Error bars represent standard error.  An n > 3 was used and 
experiments were performed in triplicate. 
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Figure 8. Activated and Total Src Localization in MLO-Y4 Osteocytes 
Under Static or OFSS Conditions 
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OFSS induces accumulation of Src at perinuclear/nuclear regions in MLO-
Y4 osteocytes.  (A) Immunofluorescence microscopy of MLO-Y4 osteocytes 
subjected to static culture conditions or OFSS for 20 minutes.  Slides were fixed 
immediately and processed for immunofluorescence using antibodies against 
activated Src (Y418 followed by FITC-conjugated secondary antibodies).  F-actin 
was visualized using Texas-Red Phalloidin and the nucleus was visualized using 
DAPI. White arrows indicate focal adhesions, highlights Src’s increased 
activation at the plasma membrane in response to OFSS.  Scale bars=25µm (B) 
Immunofluorescence microscopy of MLO-Y4 osteocytes subjected to static 
culture conditions or OFSS for 20 minutes.  Slides were fixed immediately and 
processed for immunofluorescence using antibodies against total Src followed by 
FITC-conjugated secondary antibodies.  F-actin was visualized using Texas-Red 
Phalloidin and the nucleus was visualized using DAPI.  Scale bars=25µm 
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Nuclear Src activity increases in response to OFSS  
 To directly examine changes in the sub-cellular distribution of Src tyrosine 
kinase activity in MLO-Y4 osteocytes in response to OFSS we utilized a Src 
biosensor to measure Src activity by FRET microscopy.  The changing FRET 
signal from the Src biosensor probe was detected using fluorescent lifetime 
imaging microscopy (FLIM), which measures the shortened donor lifetime that 
results from FRET.  This approach allows us to map with pixel level resolution 
the sub-cellular locations of changing Src protein activity.  The Src biosensor 
used here is in a closed conformation under conditions of low endogenous Src 
activity, resulting in high FRET efficiency and a shortened donor lifetime. Upon 
phosphorylation of the substrate peptide by endogenous Src, the substrate binds 
to the phosphopeptide-binding pocket of the SH2 domain, resulting in a more 
open conformation and diminished FRET leading to an increased donor lifetime 
(Figure 9).  Thus, an increase in Src biosensor lifetime indicates an increase in 
Src kinase activity.   
 The phasor plot analysis comparing the total population of Src biosensor 
in MLO-Y4 cells prior to or following exposure to OFSS clearly showed a shift 
towards longer lifetimes of the Src biosensor, indicating a global increase in Src 
activity throughout MLO-Y4 cells in response to OFSS (Figure 10).  Following 
exposure to 5 minutes of OFSS, lifetimes of the Src biosensor donor fluorophore 
were determined for three distinct sub-cellular compartments (regions of interest, 
ROI) – the membrane, cytoplasm and nucleus - at 10, 15 and 20 minutes post-
OFSS using FLIM analysis.  Prior to OFSS, Src activity in the nucleus was  
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Figure 9. Diagram of the Src Biosensor 
 
The Src biosensor is capable of detecting changes in endogenous Src 
kinase activity.  (A) The structure of the Src biosensor.  The Src biosensor is 
made up of a donor fluorophore (ECFP) fused to the Src Homology 2 (SH2) of 
cytosolic Src (c-Src).  A short amino acid linker connects ECFP and SH2 to the 
acceptor fluorophore (YPet) and c-Src substrate that can be phosphorylated by 
endogenous Src.  Two mutants of the Src biosensor were generated to cause the 
Src biosensor to remain in a closed confirmation.  The R175 site within the SH2 
domain was mutated, as well as, the two key phosphorylation sites within the 
p130Cas substrate.  (B) The Src biosensor is in a closed conformation under 
conditions of low endogenous Src activity, resulting in high FRET efficiency and a 
shortened donor lifetime. Upon phosphorylation of the substrate peptide by 
endogenous Src, the substrate binds to the phosphopeptide-binding pocket of 
the SH2 domain, resulting in a more open conformation and diminished FRET 
leading to an increased donor lifetime.  This is a dynamic and reversible process.  
Figure was adapted from Wang et al., 2005 (Hum et al., 2012). 
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Figure 10. Phasor Plot of the Src Biosensor’s Donor Lifetime in MLO-Y4 
Osteocytes Under Static and OFSS Conditions 
 
A global increase in Src activity occurs in response to OFSS.  Phasor plot 
overlay of static Src biosensor lifetime and 20 minutes post-OFSS Src biosensor 
lifetime.  The phasor plot analysis displays a shift towards longer lifetimes of the 
Src biosensor, indicating an increase in Src activity throughout MLO-Y4 cells in 
response to OFSS. 
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significantly lower than at either the membrane or in the cytoplasm (Figure 11).  
Most importantly, significant increase in nuclear Src activity was seen at each 
time point measured following OFSS and increased steadily during the 20 min 
post-OFSS period (Figure 12).  Prior to OFSS, the average lifetime of the Src 
biosensor in the nucleus was 1.69 + 0.01 nanoseconds. At 10, 15 and 20 
minutes post-OFSS nuclear Src biosensor lifetimes significantly increased 
compared to static (1.80 + 0.01, 1.90 + 0.02, and 1.95 + 0.02 nanoseconds, 
respectively) (Figure 12).  Lifetime maps of the nucleus under static and post-
OFSS conditions illustrate the increase in Src activity in response to OFSS 
(Figure 13).  In contrast, Src activity at the membrane and in the cytoplasm 
peaked at 10 and 15 minutes post-OFSS, respectively, and then decreased at 20 
minutes post-OFSS (Figure 11). 
 In sharp contrast, there was no change in the fluorescent lifetime of a 
mutant Src biosensor (Y662F Y664F) following 5 minutes of OFSS (Figure 14).  
The mutation of the tyrosine residues in the p130Cas substrate blocks Src 
tyrosine kinase activation of the biosensor, and also changes its confirmation, 
resulting in higher basal lifetimes compared to the Src biosensor (Figure 15). 
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Figure 11. Subcellular Measurements of the Src Biosensor’s Donor 
Lifetimes in MLO-Y4 Osteocytes in Response to OFSS 
 
 
 
 
 
 
 
 
 
 
In response to OFSS the subcellular regions of Src activity change.  MLO-
Y4 osteocytes expressing the Src biosensor were exposed to 5 minutes of 
OFSS.  Images were taken 10, 15, and 20 minutes post-OFSS.  A distinct pattern 
of Src activity develops in the three regions of interest (ROI) examined: plasma 
membrane, cytoplasm, and nucleus.  The plasma membrane displays a  
significantly longer lifetime 10 minutes after exposure to OFSS compared to the 
other ROI (*p<0.05).  Fifteen minutes after OFSS the cytoplasm displays the 
longest lifetimes.  Lifetimes in the nucleus are significantly longer 20 minutes 
after exposure to OFSS (*p<0.05).  Graph represents n=3 in which the average 
lifetime of each ROI (30) at each time point analyzed. Error bars represent 
standard error. 
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Figure 12. Lifetimes of Src Biosensor in the Nucleus of MLO-Y4 
Osteocytes in Response to OFSS 
 
Src activity increases in the nucleus in response to OFSS.  A significant 
increase in nuclear Src activity was seen at each time point measured following 
OFSS.  Graph represents an N=3, with the average of 30 ROI’s examined at 
each time point.  Error bars represent standard error.  *p<0.05 versus the static 
control, #p<0.05 versus other OFSS time points examined 
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Figure 13. Lifetime Maps of the Src Biosensor Under Static or OFSS 
Conditions 
 
Nuclear Src activity increases in response to OFSS.  Lifetime maps of two 
MLO-Y4 osteocytes under both static and 20 minutes post-OFSS conditions.  
Areas of short donor lifetimes are indicated by cooler colors, while longer donor 
lifetimes are indicated by warmer colors. 
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Figure 14.  Phasor Plot of the Mutant Src Biosensor 
 
OFSS does not change the lifetime of the mutant Src biosensor.  MLO-Y4 
osteocyte cells expressing the mutant Src biosensor we analyzed under static 
conditions and then exposed to 5 minutes of OFSS.  Next, lifetime images were 
taken at 10, 15, and 20 minutes post-OFSS.  The phasor plot above was 
generated from the overlaid phasor plots of the same static and 20 minutes post-
OFSS MLO-Y4 osteocyte. 
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Figure 15.  Lifetime Maps of the Mutant Src Biosensor Under Static or OFSS 
Conditions 
  
 
OFSS does not induce a change in the mutant Src biosensor’s lifetimes in 
the nucleus.  Mutant Src biosensor lifetimes in MLO-Y4 osteocytes were 
analyzed under static conditions and after exposure to 5 minutes of OFSS.  In 
nucleus, no change in lifetime occurs in the mutant Src biosensor.  Areas of short 
donor lifetimes are indicated by cooler colors, while longer donor lifetimes are 
indicated by warmer colors. 
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Src activation increases in the nucleus in response to OFSS  
 To validate the observation of increased Src activity in the nucleus of 
MLO-Y4 cells in response to OFSS; nuclear fractionation followed by Western 
blot analysis was performed. MLO-Y4 osteocytes were exposed to either static 
conditions (control) or 5 minutes of OFSS.  The control cells or OFSS cells were 
collected 10 minutes-post-OSS.  Src activation, as measured by phosphorylation 
at Y418, was performed by Western blot.  In response to 5 minutes of OFSS 
activated Src in the nucleus was increased at 10 minutes post-OFSS compared 
to static conditions (Figure 16). 
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Figure 16.  Nuclear Fractionation of MLO-Y4 Osteocytes  
  
Nuclear Src activation increases in response to OFSS.  (A) Western blot 
analysis of nuclear fractionation blotted for Src activation (Y418), total Src and 
lamin B in MLO-Y4 osteocytes exposed to 5 minutes of OFSS or static culture 
conditions. (B) Graph represents quantification of Src activation (Y418)/total Src in 
nuclear fractions. Error bars represent standard error. Statistically significant 
difference between static and 10 minutes post-OFSS (*p<0.05). An n > 3 was 
used, experiments were performed in triplicate. 
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DISCUSSION 
 
 The goal of this study was to investigate a potential role for Src tyrosine 
kinase in transcriptional regulation of anabolic gene expression in MC3T3 
osteoblasts and MLO-Y4 osteocytes, principally in response to OFSS.  
Expression of osteocalcin, a marker of bone formation in vivo, was increased 
when Src activity was inhibited in MC3T3 osteoblasts and MLO-Y4 osteocytes.  
Furthermore, we show for the first time that the increase in osteocalcin 
expression normally induced by OFSS was further enhanced in MC3T3 
osteoblasts and MLO-Y4 osteocytes when Src activity was inhibited by treated 
with SI1 compared to control cells in which Src activity was not inhibited.  We 
used a Src biosensor to demonstrate an increase in Src activity in the nucleus of 
MLO-Y4 osteocytes in response to OFSS that was further confirmed using 
nuclear fractionation. Together these results support the novel concept that Src 
plays a role in bone remodeling by functioning to curb the anabolic response of 
MC3T3 osteoblasts and MLO-Y4 osteocytes to OFSS via a mechanism that 
involves a mechanically-induced increase in nuclear Src activity.  
 Inhibition of Src caused an increase in osteocalcin mRNA in MC3T3 
osteoblasts not subjected to fluid flow, while a flow-induced increase in 
osteocalcin mRNA normally induced by mechanical stimulation was further 
enhanced by Src inhibition compared to control cells (Figure 7).  Interestingly, in 
MLO-Y4 osteocytes Src inhibition under static conditions fails to increase 
osteocalcin expression.  Only after exposure to OFSS, does Src inhibition lead to 
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an increase in osteocalcin expression (Figure 7).  Thus, our results suggest Src 
normally functions to attenuate osteocalcin expression under conditions of both 
static culture and OFSS.  Osteocalcin is an important protein associated with 
bone formation and its levels in serum directly correlate with measurements of 
bone mineral density (Delmas et al., 1990; Wolf, 1996).  Osteocalcin expression 
is increased in response mechanical loading in both in vivo and in vitro models 
(Kannus et al., 1996; Raab-Cullen et al., 1994).  Here we suggest, for the first 
time, that Src activity affects the expression of osteocalcin in both static and 
OFSS conditions.  
 Taken together our immunolocalization, FRET microscopy and nuclear 
fractionation studies suggest that exposure of MLO-Y4 cells to OFSS results in 
an increase in the amount of activated Src (Y418 phosphorylation) in the 
perinuclear/nuclear regions and an increase in Src tyrosine kinase activity in the 
nucleus in response to OFSS.  A subtle increase in total Src in the 
perinulear/nuclear region was seen in response to OFSS. In contrast, a more 
pronounced increase in activated Src (Y418) was seen in the perinuclear and/or 
nuclear regions of MLO-Y4 osteocytes (Figure 8) suggesting that the population 
of Src that accumulates in this region is activated (as assessed by Y418 
phosphorylation).  Our nuclear fractionation and FRET data directly demonstrate 
that Src tyrosine kinase activity increased in the nucleus in response to OFSS.  
This novel result suggests a previously unrecognized role for Src tyrosine kinase 
activity in regulating the transcriptional response of MLO-Y4 osteocytes to OFSS.  
There is not a widely accepted mechanism to explain how Src translocates into 
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the nucleus, however myrstoylation has been suggested to function in regulating 
transport of Src to the nucleus (David-Pfeuty et al., 1993).  Additionally, 
myristoylation is one of the ways in which Src maintains its distribution at the 
plasma membrane where it can participate in integrin-mediated signaling 
responses to mechanical loading (Resh, 1994).  A hydrophobic pocket is 
predicted to exist in the SH-1 kinase domain of Src, enabling Src to switch 
between its myristoylated and nonmyristolated forms (Cowan-Jacob et al., 2005).  
An increase in nuclear Src activation (Y418) was reported in breast cancer tissue 
samples and correlated with improved patient outcome (Campbell et al., 2008).   
 We have characterized the formation and function of load-induced multi-
protein complexes termed “mechanosomes” that mediate mechanotransduction 
in bone cells (Bidwell and Pavalko, 2010; Bidwell and Pavalko, 2011; Pavalko et 
al., 2003b).  We propose the existence of mechanosomes that either promote 
(“GO”) or attenuate (“STOP”) load-induced bone formation.  β-catenin/Lef1 is an 
example of a “GO” mechanosome, while NMP4/p130Cas functions as a “STOP” 
mechanosome (Childress et al., 2010; Jackson et al., 2005; Robinson et al., 
2006; Tamamura et al., 2005; Yang et al., 2010).  The Pilz group has described a 
mechanosome made up of protein kinase G, Src and Src homology 2 domain-
containing tyrosine phosphatase 1 and 2 (Rangaswami et al., 2010).  Our results 
extend these findings to suggest that OFSS enhances the activity of a Src-
containing “STOP” mechanosome to attenuate the anabolic response of 
osteoblasts and osteocytes to loading. “STOP” mechanosomes function to 
prevent the overreaction of “GO” mechanosomes to OFSS, preventing the 
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overexpression of anabolic bone genes.  For instance, OFSS-induces an 
increase in osteocalcin expression in both MC3T3 osteoblasts and MLO-Y4 
osteocytes, which we propose is limited by the activity of a Src-containing 
“STOP” mechanosome.  When Src activity is inhibited under OFSS conditions, 
the expression of osteocalcin is further enhanced due to the absence of activity 
from a Src-containing “STOP” mechanosome that functions to attenuate the 
expression of anabolic bone genes.  Under static conditions inhibiting the activity 
of Src causes a modest increase in osteocalcin expression.  This suggests that a 
Src-containing “STOP” mechanosome may have a role in attenuating the 
transcription of anabolic bone genes under static conditions as well. 
 We suggest that increased Src tyrosine kinase activity in the nucleus in 
response to mechanical loading may serve as transient “off switch” to attenuate 
the anabolic response of bone to mechanical loading.  Once activated by 
mechanical stimulation, Src may further increase its activity in the nucleus and 
participate in a mechanism to prevent an over-reaction to physical stimulation.  
Clinical trials are underway testing the effectiveness of Src inhibitors on 
suppressing bone resorption by osteoclasts.  Our results suggest the possibility 
that load-bearing exercise could enhance the efficacy of Src inhibitors in patients 
treated with Src inhibitor.  Further studies will be needed to determine the 
detailed molecular mechanism(s) by which Src activation and activity in the 
nucleus regulates gene expression. It is noteworthy however that a previous 
report suggested that Src might be capable of regulating methyl-CpG-binding 
domain protein 2 (MBD2) mediated expression of the myogen promoter during 
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skeletal muscle differentiation (Luo et al., 2009).  Src may also function as a 
“STOP” mechanosome by targeting the activity of activator protein 1 (AP1) 
transcription factor to suppress anabolic bone gene transcription.  The C-terminal 
region of Src can negatively regulate AP1 activity.  AP1 is a heterodimer 
comprised of two transcription factors, c-fos and c-jun.  Src can bind and 
phosphorylate c-Jun at Y26 and Y170 resulting in the ubiquitination of c-Jun and 
decreased AP1 activity (Zhu et al., 2006).  Since osteocalcin contains an AP1 
binding site in its promoter region, this may serve as a mechanism by which Src 
activity could regulate anabolic bone gene transcription (Lian et al., 1989). 
 Using FRET microscopy with FLIM analysis to investigate endogenous 
Src tyrosine kinase activity permits the mapping the sub-cellular locations of 
changing Src activity in living cells.  FLIM analysis does not require corrections 
for spectral-bleed through, which is necessary for other FRET-based imaging 
approaches. The Src biosensor used here is in a closed conformation under 
conditions of low endogenous Src activity, resulting in high FRET and shortened 
donor lifetimes. Upon phosphorylation of the substrate peptide by endogenous 
Src, the substrate binds to the phosphopeptide-binding pocket of the SH2 
domain, resulting in an open conformation and diminished FRET leading to an 
increased donor lifetime. Through the use of a Src biosensor we observed that 
mechanical stimulation by fluid flow increases Src activity in the nucleus of MLO-
Y4 osteocytes 20 minutes after exposure to a brief (5 min) bout of OFSS.  This 
approach confirmed that OFSS initially (10 min post-OFSS) has the greatest 
impact on activity of Src that is localized at the membrane (where integrins detect 
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OFSS stimulation).  Subsequently, OFSS-induced Src activity was highest in the 
cytoplasm (15 min) and by 20 min the greatest increase in Src activity was seen 
in the nucleus.  There is some concern when examining a substrate 
phosphorylated by Src that related kinases such as Yes, Abl, Jak2 or the Ser/Thr 
kinase ERK1 might also produce a change in lifetime of the Src biosensor. A 
previous reported on the specificity of this Src biosensor found a change of less 
than 2% in emission ratio in the Src biosensor by Yes, Abl, Jak2 or Ser/Thr 
kinase ERK1 (Wang et al., 2005).  Additionally, the mutant Src biosensor does 
not respond to endogenous Src activity and remains in a closed conformation.  
Recently, using Src and FAK biosensors, Src activity was reported to decrease 
and FAK activity to increase during differentiation from human mesenchymal 
stem cells to osteoblasts (Liao et al., 2012).  Our study is the first to report spatial 
and temporal changes, via FLIM analysis, in Src activity in MLO-Y4 osteocytes in 
response to OFSS. 
 In conclusion we suggest Src may play a significant functional role in 
attenuating the transcription of anabolic bone genes, such as osteocalcin, in 
response to OFSS.  This effect is evident in vitro under basal (static) conditions, 
as well as, following exposure to mechanical loading (OFSS).  In vivo, load-
bearing exercise promotes skeletal health by adjusting bone remodeling and 
bone mass.  An underappreciated aspect of load-induced bone formation may be 
the existence of negative feedback signals mediated by Src within osteocyte 
directed skeletal mechanotransduction pathways that may limit the beneficial 
bone forming effects of exercise.  Pharmacological interventions that inhibit Src 
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activity could disable those negative feedback signals and dynamically enhance 
skeletal health.  Among the questions raised by this study is the precise 
molecular mechanism(s) through which Src activity is increased in the nucleus in 
response to OFSS and how it aids in repressing transcription.  Future studies will 
need to define how Src participates in attenuating anabolic bone gene 
expression by identifying Src binding partners in the nucleus that have the 
capacity to directly alter transcription and the epigenome. 
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Chapter IV 
 
Pyk2 May Function as a “STOP” Mechanosome By Interacting with MBD2 
in Osteoblasts and Osteocytes 
 
ABSTRACT 
 Pyk2 plays an important role in bone remodeling.  Pyk2 null mice exhibit 
increased bone mass, due to compromised osteoclast function.  Undefined is 
Pyk2’s role in mediating mechanotransduction in bone cells.  We tested the 
hypothesis that Pyk2 suppresses anabolic targets of OFSS-induced 
mechanotransduction in osteoblasts and osteocytes.  In this study we sought to 
determine Pyk2’s localization, effect on the abundance of proteins and transcripts 
associated with anabolic signaling, and association with other signaling 
molecules under static and OFSS conditions.  We found Pyk2 suppressed 
OFSS-induced Cox-2 protein expression and osteopontin gene expression, and 
displayed nucleocytoplasmic shuttling.  These observations of Pyk2’s effect on 
protein and gene expression and localization are consistent with the phenomena 
we have proposed of mechanosomes.  To determine whether Pyk2 may form a 
complex similar to a mechanosome, co-immunoprecipitation experiments 
examined Pyk2’s association with MBD2 under static and OFSS conditions.  A 
constitutive interaction between Pyk2 and MBD2 was observed and was not 
OFSS dependent.  However, when examining the activated form of Pyk2 (Y402), 
OFSS induced an increase in the association of Pyk2 and MBD2.  Additionally, 
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the association between activated Src (Y418) and Pyk2 (Y402) increases in 
response to OFSS.  In summary, we found that in response to OFSS Pyk2 is 
capable of nucleocytoplasmic shuttling, increased association with MBD2 and 
suppression of Cox-2 protein expression and osteopontin expression, thus 
meeting the criteria of functioning as a “STOP” mechanosome. 
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INTRODUCTION 
 
 Bone tissue adapts to changes in mechanical loading from the external 
environment by modeling and remodeling.  This is an example of 
mechanotransduction, a process by which a mechanical signal is detected and 
converted into biochemical and transcriptional responses inside the cell (French, 
1992).  On the cellular level in bone mechanical loading causes changes in 
interstitial fluid flow that is detected by osteoblasts and osteocytes.  Focal 
adhesions (FA) play an important role in mechanotransduction and are thought to 
serve as mechanosensors of osteoblasts and osteocytes (Geiger and 
Bershadsky, 2001; Thompson et al., 2012).  FA are mainly composed of 
structural proteins such as integrins, vinculin, α-actinin, and actin filaments and 
adhesion-associated signaling proteins like FAK, Pyk2, and Src (Geiger and 
Bershadsky, 2001).  Focal adhesions are ideal launching sites for either “GO” or 
“STOP” mechanosomes, in response to changes in fluid shear stress.  
Mechanosomes are made up of an adhesion-associated protein and a 
transcription factor and either serve to promote the anabolic response of bone to 
mechanical loading (“GO”) or suppress its response to mechanical loading 
(“STOP”) (Bidwell and Pavalko, 2010; Bidwell and Pavalko, 2011; Pavalko et al., 
2003b).  Much work has been done to describe protein complexes like β-
catenin/Lef1 that function as a “GO” mechanosome, however few complexes 
have been described to function as a “STOP” mechanosome.  Pharmacological 
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manipulation of “STOP” mechanosomes may prove to be a novel therapeutical 
target.  
 FAK is a non-receptor tyrosine kinase found at sites of focal adhesions.  
By associating with the integrins of FA, FAK becomes activated by 
autophosphorylation at tyrosine 397 (Calalb et al., 1995).  We have previously 
reported FAK to be important in mediating the mechanotransduction signal in 
osteoblasts exposed to OFSS (Young et al., 2009).  In response to OFSS 
osteoblasts lacking FAK fail to appropriately increase protein levels of Cox-2, c-
Fos, and osteopontin.  Furthermore, OFSS-induced IkB-β and IkB-α degradation 
and NF-kB nuclear translocation was impaired in FAK -/- osteoblasts (Young et 
al., 2010).   
 Pyk2 is another member of the FAK family of non-receptor tyrosine 
kinases and is found to associate with focal adhesions.  FAK and Pyk2 are 
closely related in structure, sharing ~45% homology (Herzog et al., 1996; 
Inazawa et al., 1996).  Pyk2 is highly expressed in osteoclasts and its role within 
osteoclast function is more clearly defined than in osteoblasts and osteocytes.  
Mice lacking Pyk2 exhibit mild osteopetrosis and impairment of osteoclast 
function (Gil-Henn et al., 2007; Okigaki et al., 2003).  More specifically, 
osteoclasts lacking Pyk2 fail to form a functional sealing zone causing impaired 
bone resorption. Pyk2’s signaling capacity in osteoblasts or osteocytes, 
particularly in response to OFSS, has not been described.  
 
 
	  79 
	  
RESULTS  
 
 OFSS-induced Cox-2 protein expression is enhanced in Pyk2 -/- 
osteoblasts 
 Wild-type MCOB and Pyk2 -/- osteoblasts were subjected to either static 
or 1 hour of OFSS.  OFSS induces a significant 1.8 fold increase in Cox-2 
expression in wild-type MCOB’s (Figure 17).  In the absence of Pyk2, the OFSS 
induced increase of Cox-2 is significantly higher than static Pyk2 -/- osteoblasts 
and elevated compared to the Cox-2 protein levels of wild-type MCOB in 
exposed to OFSS (Figure 17).  OFSS does not induce any changes in the protein 
levels Pyk2 in either the wild-type MCOB or Pyk2 -/- osteoblasts (Figure 17).  
 
Basal osteopontin expression is elevated in Pyk2 -/- osteoblasts and 
further enhanced in response to OFSS in Pyk2 -/- osteoblasts 
 To determine if Pyk2 -/- might play a role in regulating changes of gene 
transcription in response to OFSS, relative expression of mRNA was examined.  
Under static conditions, Pyk2 -/- osteoblasts expressed significantly higher levels 
of osteopontin (Figure 18).  Both wild-type MCOB and Pyk2 -/- osteoblasts were 
exposed to either static or OFSS conditions.  Using either method of inducing 
OFSS (OFSS pump or orbital shaking platform), Pyk2 -/- osteoblasts expressed 
enhanced levels of osteopontin expression compared to wild-type MCOB’s in 
response to OFSS (Figure 18). 
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Figure 17. Cox-2 Protein Expression in Wild-type MCOB and Pyk2 -/- 
Osteoblasts Under Static and OFSS Conditions 
 
 
 
Cox-2 protein expression is enhanced in Pyk2 -/- osteoblasts.  Wild-type 
MCOB and Pyk2 -/- osteoblasts were exposed to either static of one hour of 
OFSS. Representative of immunoblots for Cox-2, GAPDH, and Pyk2 show a 
OFSS-induced increase in Cox-2 protein expression.  OFSS does not cause a 
change in the loading control, GAPDH.  Confirmation of Pyk2 knockout is seen in 
bottom immunoblot.  Graph represents the densitometry units of Cox-2, 
normalized to GAPDH.  In wild-type MCOB, OFSS results in a 1.8 fold change in 
Cox-2 protein expression.  Pyk2 -/- osteoblasts have elevated levels of Cox-2 
protein under static conditions, and after OFSS the level of Cox-2 protein 
expression is highest compared to all other groups (static control, wild-type 
MCOB static control, and wild-type MCOB OFSS). Error bars represent standard 
error. *p<0.05 vs. static control; #p<0.05 vs. wild-type MCOB. N=3 in three 
separate trials. 
	  81 
	  
 Figure 18. Osteopontin Expression in Wild-type MCOB and Pyk2 -/- 
Osteoblasts Under Static and OFSS Conditions 
 
 
 
 
 
 
 
 
 
 
 
 
Osteopontin expression is elevated in Pyk2 -/- osteoblasts under static 
conditions and further enhanced after exposed to OFSS.  Wild-type MCOB 
and Pyk2 -/- osteoblasts were exposed to either static or 1 hour of OFSS 
conditions, using either an OFSS pump or orbital shaking platform.  Static Pyk2   
-/- osteoblasts expressed significantly higher levels of osteopontin compared to 
static wild-type MCOBs.  In response to OFSS, using either method, the absence 
of Pyk2 further enhances the OFSS-induced osteopontin expression. Error bars 
represent standard error.  *p<0.05 vs. static control, #p<0.05 vs wild-type MCOB. 
N=3 in three separate trials. 
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Pyk2 accumulates in the nucleus in response to OFSS 
 After observing OFSS-induced changes in anabolic gene transcription in 
the absence of Pyk2 we next monitored the distribution of Pyk2 after periods of 
OFSS.  Immunofluorescent microscopy was used to examine the cellular 
distribution of Pyk2 in MCOB’s that were exposed to either static conditions or 
OFSS (30 minutes, 1 hour, or 1 hour + 1 hour of rest).  Static MCOBs displayed a 
relatively even distribution of Pyk2 throughout the cells, with a subtle 
concentration of Pyk2 in the perinuclear/nuclear region (Figure 19).  In response 
to 30 minutes of OFSS, Pyk2 preferentially accumulates in the nucleus of 
MCOB’s (Figure 19).  After exposure to an hour of OFSS, the accumulation of 
Pyk2 in the nucleus is less robust than at the 30 minute OFSS time point (Figure 
19).  In response to 1 hour of OFSS and 1 hour of rest, Pyk2’s absence in the 
nucleus is even further enhanced compared to static.  This suggests that Pyk2 is 
capable of shuttling between the cytoplasm and the nucleus in response to 
OFSS (Figure 19). 
 
Pyk2 and MBD2 complex under basal conditions and increase their 
association in response to OFSS 
 To further determine if Pyk2 plays a nuclear role in the regulation of 
anabolic bone genes, we examined its association with MBD2.  We performed a 
co-immunoprecipation assay to examine the possibility of a Pyk2 complex with 
MBD2.  Western blot antibodies to either Pyk2 or MBD2 were used to detect 
immunoprecipitated proteins.  In static osteoblast lysates, endogenous Pyk2  
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Figure 19. Immunofluorescence of Pyk2’s Localization in MCOB Under 
Static and OFSS Conditions  
 
 
 
OFSS-induces Pyk2 nucelocytoplasmic shuttling. Immunofluorescence 
microscopy of MCOB’s subjected to either static culture conditions or OFSS (30 
minutes, 1 hour, or 1 hour + 1 hour of rest).  Slides were fixed immediately and 
processed for immunofluorescence using antibodies against Pyk2, followed by 
FITC-conjugated secondary antibodies.  The nucleus was visualized using DAPI. 
Scale bars = 100µm 
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forms a complex with MBD2 (Figure 20).  A complex of Pyk2/MBD2 was detected 
using antibodies to either Pyk2 or MBD2.  Next, we compared the association of 
Pyk2/MBD2 under static and OFSS conditions using antibodies for the activated 
form of Pyk2 (Y402).  In response to 20 minutes of OFSS MBD increases its 
interaction with the activated Pyk2 (Y402) (Figure 21).  Additionally, OFSS-
induced an association of Pyk2 (Y402) and Src (Y418) (Figure 21). 
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Figure 20. Co-immunoprecipitation Between MBD2 and Pyk2 in MLO-Y4 
Osteocytes 
 
 
 
A complex between MBD2 and Pyk2 forms under static conditions in MLO-
Y4 osteocytes.  Co-immunoprecipitation between MBD2 and Pyk2 was 
performed from MLO-Y4 osteocytes harvested under static conditions.  MBD2 
was not associated with Pyk2 when control normal mouse Ig was used in the 
immunoprecipitation.  Anti-MBD2 antibody was used to probe the blot.   
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Figure 21. Co-immunoprecipitation Between MBD2 and Pyk2 (Y402) and 
Src (Y418) and Pyk2 (Y402) in MLO-Y4 osteocytes. 
 
 
OFSS-induces the association of MBD2 and Pyk2 (Y402) and Src (Y418) and 
Pyk2 (Y402) in MLO-Y4 osteocytes.  Co-immunoprecipitation was performed in 
MLO-Y4 osteocytes harvested under static (S) or OFSS (F) conditions.  Normal 
rat serum (NRS), MBD2, and Src (Y418) were the antibodies used for the 
immunoprecipitation.  Anti-Pyk2 (Y402) specific antibody was used to probe the 
blot. 
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DISCUSSION 
 
 In this study the potential for Pyk2 to function as a “STOP” mechanosome 
was examined.  In the absence of Pyk2, Cox-2 and osteopontin expression are 
modestly increased.  OFSS, induced by either oscillatory pump or orbital shaking 
platform, further enhanced Cox-2 and osteopontin expression in Pyk2 null 
osteoblasts. Therefore, Pyk2 functions to suppress the expression of the 
anabolic bone gene osteopontin and protein expression of Cox-2 under static 
and OFSS conditions.  To further evaluate the potential “STOP” mechanosome 
properties of Pyk2, immunofluorescence was used to visualize the localization of 
Pyk2 under static and OFSS conditions.  MCOB under static conditions displayed 
a fairly even distribution of Pyk2, with a subtle concentration of Pyk2 in the 
perinuclear/nuclear region (Figure 19).  Pyk2 appeared to be capable of shuttling 
in and out of the nucleus in response to OFSS, as seen by an accumulation of 
Pyk2 in the nucleus (after 30 minutes of OFSS) and later an absence in the 
nucleus (1 hour of OFSS and 1 hour of rest). An OFSS-induced 
nucleocytoplasmic shuttling mechanism of Pyk2 has yet to be described, but 
other studies in fibroblasts have observed Pyk2’s nucleocytoplasmic shuttling 
behavior in response to membrane depolarization (Faure et al., 2007; Faure et 
al., 2013).  The nucleocytoplasmic shuttling of Pyk2 is possible through the 
nuclear localization sequence (NLS) and the nuclear export sequence (NES) that 
are both located in the FERM domain (Figure 2) (Lim et al., 2008a; Lim et al., 
2010; Ossovskaya et al., 2008).  While more work will need to be done to define 
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the molecular mechanism(s) that cause OFSS-induced nucleocytoplasmic 
shuttling of Pyk2, this behavior is a hallmark characteristic of a mechanosome. 
 If Pyk2 is to function as a mechanosome it must also complex with a 
transcription factor and bind to target gene(s) to alter transcription.  Pyk2 null 
osteoblasts exhibit increased levels of the protein Cox-2, as well as increased 
expression of osteopontin under basal conditions.  OFSS-induced increases in 
Cox-2 and osteopontin were further enhanced in the absence of Pyk2.  These 
changes in Cox-2 protein expression and osteopontin transcription might be 
mediated by the OFSS-induced increased in the association of Pyk2 and MBD2.  
In MLO-Y4 osteocytes a basal interaction between Pyk2 and MBD2 was 
observed.  When examining the activated form of Pyk2 (Y402), an increase in its 
association with MDB occurs in response to 20 minutes of OFSS.  While not a 
transcription factor, MBD2 is a member of the methyl CpG-binding protein family 
and functions to repress transcription (Boeke et al., 2000; Hendrich and Bird, 
1998; Ng et al., 1999).  Specifically, MBD2 and methyl CpG binding protein 2 
(MeCP2) bind heterochromatin through their interaction with methylated DNA at 
CpG islands.  The complex then translates the DNA methylation signal into 
transcriptional repression by recruiting histone deacetylases and other silencing 
complexes to sustain a heterochromatic state (Bird and Wolffe, 1999; Leonhardt 
and Cardoso, 2000).  In muscles cells the interaction of FAK and MBD2 in the 
nucleus has been observed during differentiation, leading to the disruption of the 
repression complex and increased expression of myogenin (Luo et al., 2009).  
Similarly, in response to membrane depolarization Pyk2 binds MBD2 in the 
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nucleus of nerve cells, but the functional outcome of this observation has yet to 
be explained (Faure et al., 2007).  Alternatively, in fibroblasts, a nuclear 
accumulation of Pyk2 was accompanied by an accumulation of Hic-5 (Aoto et al., 
2002).  Pyk2 and Hic-5 are both found at FA sites and in the nucleus.  Hic-5 can 
bind the FAT domain of Pyk2 (Figure 2).  Hic-5 is both an adhesion-associated 
protein and co-activator of nuclear receptors.  Finally, Hic-5, along with Pyk2, 
shuttle away from sites of FA in response to cyclic strain in osteoblasts 
(Guignandon et al., 2006). 
 In summary, this study supports the hypothesis that Pyk2 may function as 
part of a “STOP” mechanosome.  Pyk2 represses the expression of anabolic 
protein and gene expression under basal conditions, as well as, in response to 
OFSS.  Typical of proposed mechanosome behavior, OFSS-induced 
nucleocytoplsmic shuttling of Pyk2.  While a complex of Pyk2 and MBD2 exists 
under static conditions, OFSS enhances their association.  A Pyk2/MBD2 
“STOP” mechanosome may repress the transcription of anabolic bone genes 
through MBD2’s transcriptional repression capabilities.  Future studies will need 
to examine the specificity of a Pyk2/MBD2 “STOP” mechanosome gene target(s) 
and explain mechanistically how transcription is repressed. 
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CONCLUSIONS AND PERSPECTIVES 
 
 The aim of this thesis study was to better understand the signaling 
mechanisms that osteoblasts and osteocytes use to suppress the anabolic 
response of bone to mechanical loading.  The roles of Src and Pyk2 were 
examined due to their shared knockout phenotype, increased bone mass.  I 
investigated the capacity of Src and Pyk2, two adhesion-associated proteins, to 
function as “STOP” mechanosomes in osteoblasts and osteocytes.  After initially 
finding that inhibiting Src activity caused an increase in osteocalcin expression, 
which was further enhanced in response to OFSS, Src’s pattern of activity in 
response to OFSS was examined.  OFSS-induced a pattern of increased Src 
activity that started at the plasma membrane and propagated to the nucleus.  A 
novel observation in bone cells; Src has not previously been reported to function 
in the nucleus in response to OFSS.  In further experimentation, it was confirmed 
by nuclear fractionation that OFSS-induced an increase in Src activation.  Prior to 
the initiation of this project, it was thought that Src’s role in response to OFSS 
was limited to its location at sites of FA.  Previously, it was shown that OFSS-
induces an increase in Src activation, as observed from whole cell lysates, and 
serves to propagate signaling pathways.  Through the use of a pharmacological 
inhibitor of Src activity, a biosensor for Src, and traditional molecular biology 
techniques I discovered that in response to OFSS Src’s role extends beyond its 
functions at the plasma membrane.  These data suggest, for the first time, Src 
may participate in a “STOP” mechanosome aiding in the attenuation of 
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expression of osteocalcin, an anabolic bone gene (Figure 22).  Further studies 
will examine the mechanisms by which Src suppresses gene transcription in 
response to OFSS. 
 Next, the potential of Pyk2 to function as part of a “STOP” mechanosome 
was examined.  The absence of Pyk2 caused modest increases in Cox-2 protein 
expression and osteopontin expression.  The first indication that Pyk2 might 
function as a “STOP” mechanosome was demonstrated when OFSS-induced 
enhanced expression of Cox-2 and osteopontin expression in Pyk2 null 
osteoblasts.  OFSS-induces Pyk2 nucleocytoplasmic shuttling, suggesting Pyk2 
localizes like a “STOP” mechanosome.  Further, these data indicate MBD2 
associates with Pyk2 under static conditions, but more importantly OFSS-induces 
an increase in Pyk2 and MBD2 association.  MBD2 could serve as the 
mechanism by which a Pyk2-contining “STOP” mechanosome functions to 
suppress gene transcription (Figure 22).  Since activated Src increases its 
association with activated Pyk2 in response to OFSS, future studies will need to 
examine the possibility of a Src/Pyk2/MBD2 “STOP” mechanosome. 
 In conclusion, this work supports the hypothesis that “STOP” 
mechanosomes exist to suppress the anabolic response of osteoblasts and 
osteocytes to fluid shear stress.  OFSS-induces Src and Pyk2 activation and 
subsequent suppression of anabolic protein and gene expression.  In response 
to OFSS, Src may increase its activity in the nucleus and suppress gene 
transcription by association with a repression complex.  OFSS-induces the 
nucleocytoplasmic shuttling which leads to an increased association with MBD2  
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Figure 22. Summary Figure  
 
“GO” and “STOP” Mechanosomes Relay OFSS-induced Signals That 
Result in Changes in Gene Transcription.  The findings in this dissertation 
support the proposed “STOP” mechanosome model.  Specifically, OFSS-induced 
the nuclear activity of Src and Pyk2, resulting in the suppression of anabolic bone 
genes.  The discovery of two new “STOP” mechanosomes complements findings 
of the “GO” mechanosome, β-catenin and Lef1.  A dotted line was used for the 
Src mechanosome because it is unknown whether it translocates to the nucleus 
or if a nuclear form of Src carries out gene suppression. 
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and repression of the anabolic bone gene, osteocalcin.  Taken together these 
data support the mechanosome hypothesis, and indicate that “STOP” 
mechansomes are triggered for activation in response to OFSS and actively 
suppress anabolic bone genes. 
 Future studies will be necessary to further describe how “STOP” 
mechanosomes function to balance the response of “GO” mechanosomes to 
mechanical loading.  Specifically, it will be important to describe the 
mechanism(s) by which “STOP” mechanosomes participate in repressing 
anabolic bone gene transcription.  Therapeutically manipulating “STOP” 
mechanosomes to inhibit negative feedback signals could enhance bone mass.  
Pharmacologically targeting “STOP” mechanosomes could provide increased 
sensitivity and magnitude of the anabolic response of bone to loading, which 
would be particularly important for patients with decreased mobility and/or 
muscle strength. 
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